General Electric (GE) 10-Q 22 Oct 24 2024 Q3 Quarterly report Financial data

COVER

COVER	9 Months Ended
	Sep. 30, 2024 shares
Entity Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Sep. 30, 2024
Document Transition Report	false
Entity File Number	001-00035
Entity Registrant Name	GENERAL ELECTRIC COMPANY
Entity Incorporation, State or Country Code	NY
Entity Tax Identification Number	14-0689340
Entity Address, Address Line One	1 Neumann Way
Entity Address, City or Town	Evendale
Entity Address, State or Province	OH
Entity Address, Postal Zip Code	45215
City Area Code	617
Local Phone Number	443-3000
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding	1,082,294,004
Amendment Flag	false
Entity Central Index Key	0000040545
Current Fiscal Year End Date	--12-31
Document Fiscal Period Focus	Q3
Document Fiscal Year Focus	2024
Common Stock
Entity Information [Line Items]
Title of 12(b) Security	Common stock, par value $0.01 per share
Trading Symbol	GE
Security Exchange Name	NYSE
0.875% Notes Due 2025
Entity Information [Line Items]
Title of 12(b) Security	0.875% Notes due 2025
Trading Symbol	GE 25
Security Exchange Name	NYSE
1.875% Notes Due 2027
Entity Information [Line Items]
Title of 12(b) Security	1.875% Notes due 2027
Trading Symbol	GE 27E
Security Exchange Name	NYSE
1.500% Notes Due 2029
Entity Information [Line Items]
Title of 12(b) Security	1.500% Notes due 2029
Trading Symbol	GE 29
Security Exchange Name	NYSE
7.5% Guaranteed Subordinated Notes Due 2035
Entity Information [Line Items]
Title of 12(b) Security	7 1/2% Guaranteed Subordinated Notes due 2035
Trading Symbol	GE /35
Security Exchange Name	NYSE
2.125% Notes Due 2037
Entity Information [Line Items]
Title of 12(b) Security	2.125% Notes due 2037
Trading Symbol	GE 37
Security Exchange Name	NYSE

STATEMENT OF EARNINGS (LOSS) (U

STATEMENT OF EARNINGS (LOSS) (UNAUDITED) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Revenues
Insurance revenues (Note 12)	$ 899	$ 842	$ 2,649	$ 2,480
Total revenues	9,842	9,302	27,890	25,893
Costs and expenses
Selling, general and administrative expenses	1,330	1,001	3,280	2,846
Separation costs	74	147	408	474
Research and development	331	247	901	715
Interest and other financial charges	251	270	762	767
Insurance losses, annuity benefits and other costs (Note 12)	714	710	2,008	2,129
Goodwill impairments (Note 7)	251	0	251	0
Non-operating benefit cost (income)	(207)	(244)	(628)	(731)
Total costs and expenses	8,970	8,124	24,529	22,883
Other income (loss) (Note 18)	1,021	(845)	1,965	5,755
Earnings (loss) from continuing operations before income taxes	1,893	333	5,327	8,765
Benefit (provision) for income taxes (Note 15)	(198)	(26)	(567)	(493)
Earnings (loss) from continuing operations	1,695	307	4,760	8,272
Earnings (loss) from discontinued operations, net of taxes (Note 2)	147	31	(85)	(415)
Net earnings (loss)	1,842	338	4,676	7,857
Less net earnings (loss) attributable to noncontrolling interests	(10)	(14)	18	(37)
Net earnings (loss) attributable to the Company	1,852	352	4,657	7,894
Preferred stock dividends	0	(91)	0	(295)
Net earnings (loss) attributable to common shareholders	1,852	261	4,657	7,599
Amounts attributable to common shareholders
Earnings (loss) from continuing operations	1,695	307	4,760	8,272
Less net earnings (loss) attributable to noncontrolling interests, continuing operations	(10)	1	(5)	7
Earnings (loss) from continuing operations attributable to the Company	1,705	306	4,766	8,264
Preferred stock dividends	0	(91)	0	(295)
Earnings (loss) from continuing operations attributable to common shareholders	1,705	215	4,766	7,970
Earnings (loss) from discontinued operations attributable to common shareholders	147	46	(108)	(371)
Net earnings (loss) attributable to common shareholders	$ 1,852	$ 261	$ 4,657	$ 7,599
Earnings (loss) per share from continuing operations (Note 17)
Diluted earnings (loss) per share (in dollars per share)	$ 1.56	$ 0.20	$ 4.34	$ 7.25
Basic earnings (loss) per share (in dollars per share)	1.57	0.20	4.38	7.32
Net earnings (loss) per share (Note 17)
Diluted earnings (loss) per share (in dollars per share)	1.70	0.24	4.24	6.92
Basic earnings (loss) per share (in dollars per share)	$ 1.71	$ 0.24	$ 4.28	$ 6.98
Equipment
Revenues
Sales	$ 2,448	$ 2,298	$ 7,044	$ 6,804
Costs and expenses
Cost of sales	2,625	2,443	7,391	7,187
Services
Revenues
Sales	6,495	6,162	18,198	16,608
Costs and expenses
Cost of sales	$ 3,601	$ 3,549	$ 10,155	$ 9,496

STATEMENT OF FINANCIAL POSITION

STATEMENT OF FINANCIAL POSITION (UNAUDITED) - USD ($) $ in Millions	Sep. 30, 2024	Dec. 31, 2023
Statement of Financial Position [Abstract]
Cash, cash equivalents and restricted cash	$ 13,724	$ 15,204
Investment securities (Note 3)	2,232	5,706
Current receivables (Note 4)	8,936	8,703
Inventories, including deferred inventory costs (Note 5)	9,718	8,284
Current contract assets (Note 8)	2,884	2,875
All other current assets (Note 9)	1,156	1,244
Assets of businesses held for sale (Note 2)	0	541
Current assets	38,649	42,556
Investment securities (Note 3)	39,514	38,000
Property, plant and equipment – net (Note 6)	7,254	7,246
Goodwill (Note 7)	8,754	8,948
Other intangible assets – net (Note 7)	4,371	4,642
Contract and other deferred assets (Note 8)	4,823	4,785
All other assets (Note 9)	13,836	11,695
Deferred income taxes (Note 15)	7,491	7,502
Assets of discontinued operations (Note 2)	2,006	47,927
Total assets	126,698	173,300
Short-term borrowings (Note 10)	1,681	1,108
Accounts payable (Note 11)	7,829	7,516
Progress collections (Note 8)	6,477	6,177
Contract liabilities and deferred income (Note 8)	9,047	8,322
Sales discounts and allowances (Note 14)	4,073	3,741
All other current liabilities (Note 14)	4,986	4,860
Liabilities of businesses held for sale (Note 2)	0	378
Current liabilities	34,093	32,103
Deferred income (Note 8)	972	975
Long-term borrowings (Note 10)	18,240	19,417
Insurance liabilities and annuity benefits (Note 12)	39,147	39,624
Non-current compensation and benefits (Note 14)	7,169	7,656
All other liabilities (Note 14)	6,647	5,708
Liabilities of discontinued operations (Note 2)	1,328	39,213
Total liabilities	107,595	144,695
Common stock (1,082,294,004 and 1,088,415,995 shares outstanding at September 30, 2024 and December 31, 2023, respectively) (Note 16)	15	15
Accumulated other comprehensive income (loss) – net attributable to the Company (Note 16)	(4,375)	(6,150)
Other capital	24,406	26,962
Retained earnings	78,889	86,553
Less common stock held in treasury	(80,061)	(79,976)
Total shareholders’ equity	18,874	27,403
Noncontrolling interests	229	1,202
Total equity	19,102	28,605
Total liabilities and equity	$ 126,698	$ 173,300

STATEMENT OF FINANCIAL POSITI_2

STATEMENT OF FINANCIAL POSITION (UNAUDITED) (Parenthetical) - shares	Sep. 30, 2024	Dec. 31, 2023
Balance Sheet Related Disclosures [Abstract]
Common stock, shares outstanding	1,082,294,004	1,088,415,995

STATEMENT OF CASH FLOWS (UNAUDI

STATEMENT OF CASH FLOWS (UNAUDITED) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Cash flows – operating activities
Net earnings (loss)	$ 4,676	$ 7,857
(Earnings) loss from discontinued operations activities	85	415
Adjustments to reconcile net earnings (loss) to cash from (used for) operating activities:
Depreciation and amortization of property, plant and equipment	625	592
Amortization of intangible assets (Note 7)	261	278
Goodwill impairments (Note 7)	251	0
(Gains) losses on equity securities (Note 18)	(723)	(5,185)
Principal pension plans cost (Note 13)	(491)	(570)
Principal pension plans employer contributions	(142)	(134)
Other postretirement benefit plans (net)	(221)	(273)
Provision (benefit) for income taxes (Note 15)	567	493
Cash recovered (paid) during the year for income taxes	(42)	(703)
Changes in operating working capital:
Decrease (increase) in current receivables	(750)	(112)
Decrease (increase) in inventories, including deferred inventory costs	(1,416)	(1,198)
Decrease (increase) in current contract assets	(7)	(1)
Increase (decrease) in contract liabilities and current deferred income	759	757
Increase (decrease) in progress collections	283	119
Increase (decrease) in accounts payable	560	724
Increase (decrease) in sales discounts and allowances	331	(147)
All other operating activities	(105)	444
Cash from (used for) operating activities – continuing operations	4,499	3,354
Cash from (used for) operating activities – discontinued operations	(1,086)	(1,304)
Cash from (used for) operating activities	3,413	2,049
Cash flows – investing activities
Additions to property, plant and equipment and internal-use software	(765)	(612)
Dispositions of property, plant and equipment	102	54
Proceeds from principal business dispositions	507	0
Net cash from (payments for) principal businesses purchased	(126)	(41)
Sales of retained ownership interests	4,080	7,037
Net (purchases) dispositions of insurance investment securities	(698)	(1,240)
All other investing activities	(3,997)	(319)
Cash from (used for) investing activities – continuing operations	(898)	4,879
Cash from (used for) investing activities – discontinued operations	(1,090)	(2,597)
Cash from (used for) investing activities	(1,987)	2,282
Cash flows – financing activities
Net increase (decrease) in borrowings (maturities of 90 days or less)	3	(64)
Newly issued debt (maturities longer than 90 days)	0	0
Repayments and other debt reductions (maturities longer than 90 days)	(733)	(3,157)
Dividends paid to shareholders	(702)	(501)
Redemption of preferred stock	0	(5,795)
Purchases of common stock for treasury	(4,159)	(945)
All other financing activities	1,139	299
Cash from (used for) financing activities – continuing operations	(4,453)	(10,163)
Cash from (used for) financing activities – discontinued operations	(98)	1,945
Cash from (used for) financing activities	(4,551)	(8,218)
Effect of currency exchange rate changes on cash, cash equivalents and restricted cash	(58)	(91)
Increase (decrease) in cash, cash equivalents and restricted cash	(3,183)	(3,978)
Cash, cash equivalents and restricted cash at beginning of year	19,755	19,092
Cash, cash equivalents and restricted cash at September 30	16,572	15,114
Less cash, cash equivalents and restricted cash of discontinued operations at September 30	(1,468)	(2,880)
Cash, cash equivalents and restricted cash of continuing operations at September 30	$ 15,104	$ 12,233

STATEMENT OF COMPREHENSIVE INCO

STATEMENT OF COMPREHENSIVE INCOME (LOSS) (UNAUDITED) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Statement of Comprehensive Income [Abstract]
Net earnings (loss)	$ 1,842	$ 338	$ 4,676	$ 7,857
Less: net earnings (loss) attributable to noncontrolling interests	(10)	(14)	18	(37)
Net earnings (loss) attributable to the Company	1,852	352	4,657	7,894
Other comprehensive income (loss)
Currency translation adjustments	72	(396)	2,161	2,085
Benefit plans	(140)	(188)	(1,127)	(2,680)
Investment securities and cash flow hedges	1,232	(1,379)	475	(1,147)
Long-duration insurance contracts	(1,504)	2,187	250	660
Less: other comprehensive income (loss) attributable to noncontrolling interests	0	1	(17)	(3)
Other comprehensive income (loss) attributable to the Company	(339)	223	1,776	(1,079)
Comprehensive income (loss)	1,503	562	6,434	6,775
Less: comprehensive income (loss) attributable to noncontrolling interests	(10)	(12)	1	(40)
Comprehensive income (loss) attributable to the Company	$ 1,513	$ 575	$ 6,433	$ 6,815

STATEMENT OF CHANGES IN SHAREHO

STATEMENT OF CHANGES IN SHAREHOLDERS' EQUITY (UNAUDITED) - USD ($) $ in Millions		Total	GE Aerospace shareholders' equity balance	Accumulated other comprehensive income (loss)	Currency translation adjustments	Benefit plans	Investment securities and cash flow hedges AOCI	Long-duration insurance contracts	Other capital	Retained earnings	Common stock held in treasury	Noncontrolling Interests balance	[3]
Beginning balance at Dec. 31, 2022				$ (2,272)				$ (983)	$ 34,173	$ 83,001	$ (81,209)
Increase (decrease) in shareholders' equity
Other comprehensive income (loss)					$ 2,086	$ (2,678)	$ (1,147)	660
Purchases											(953)
Dispositions									(1,503)		1,918
Stock-based compensation									257
Other changes	[1]								(5,698)
Net earnings (loss) attributable to the Company		$ 7,894								7,894
Dividends and other transactions with shareholders	[2]									(5,856)
Other										6
Ending balance at Sep. 30, 2023		29,860	$ 28,694	(3,351)	(3,806)	3,853	(3,075)	(323)	27,229	85,045	(80,244)	$ 1,167
Beginning balance at Jun. 30, 2023				(3,573)				(2,510)	30,426	84,873	(80,524)
Increase (decrease) in shareholders' equity
Other comprehensive income (loss)					(397)	(188)	(1,379)	2,187
Purchases											(315)
Dispositions									(491)		595
Stock-based compensation									87
Other changes	[1]								(2,793)
Net earnings (loss) attributable to the Company		352								352
Dividends and other transactions with shareholders	[2]									(180)
Other										0
Ending balance at Sep. 30, 2023		29,860	28,694	(3,351)	(3,806)	3,853	(3,075)	(323)	27,229	85,045	(80,244)	1,167
Common stock issued		15
Common stock issued		15
Beginning balance at Dec. 31, 2023		28,605		(6,150)				(3,354)	26,962	86,553	(79,976)
Increase (decrease) in shareholders' equity
Other comprehensive income (loss)					2,181	(1,120)	465	250
Purchases											(4,192)
Dispositions									(2,831)		4,107
Stock-based compensation									303
Other changes	[1]								(29)
Net earnings (loss) attributable to the Company		4,657								4,657
Dividends and other transactions with shareholders	[2]									(12,300)
Other										(21)
Ending balance at Sep. 30, 2024		19,102	18,874	(4,375)	(1,442)	666	(494)	(3,105)	24,406	78,889	(80,061)	229
Beginning balance at Jun. 30, 2024				(4,035)				(1,601)	25,282	77,349	(80,013)
Increase (decrease) in shareholders' equity
Other comprehensive income (loss)					72	(140)	1,232	(1,504)
Purchases											(1,540)
Dispositions									(953)		1,491
Stock-based compensation									71
Other changes	[1]								6
Net earnings (loss) attributable to the Company		1,852								1,852
Dividends and other transactions with shareholders	[2]									(312)
Other										0
Ending balance at Sep. 30, 2024		19,102	$ 18,874	$ (4,375)	$ (1,442)	$ 666	$ (494)	$ (3,105)	$ 24,406	$ 78,889	$ (80,061)	$ 229
Common stock issued		$ 15
[1]Included decreases of $2,795 million and $5,795 million, substantially all in Other capital related to our redemption of GE preferred stock in the three and nine months ended September 30, 2023.[2]Included a $5,300 million decrease in Retained earnings reflecting a pro-rata distribution of approximately 80.1% of the shares of GE HealthCare on January 3, 2023. Included a $11,375 million decrease in Retained earnings reflecting a distribution of all the shares of GE Vernova on April 2, 2024.[3]Included a reclassification of $1,007 million of noncontrolling interests attributable to GE Vernova to Retained earnings as a result of the separation on April 2, 2024.

STATEMENT OF CHANGES IN SHARE_2

STATEMENT OF CHANGES IN SHAREHOLDERS' EQUITY (UNAUDITED) (Parenthetical) - USD ($) $ in Millions			3 Months Ended	9 Months Ended
	Apr. 02, 2024	Jan. 03, 2023	Sep. 30, 2023	Sep. 30, 2023
Reduction of non-controlling interest	$ 1,007
Spinoff | GE HealthCare
Ownership interest disposed of		80.10%
Preferred stock
Stock repurchased			$ 2,795	$ 5,795
Retained earnings
Spinoff transaction adjustment	$ 11,375	$ 5,300

BASIS OF PRESENTATION AND SUMMA

BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	9 Months Ended
	Sep. 30, 2024
Accounting Policies [Abstract]
BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES. Our financial statements are prepared in conformity with U.S. generally accepted accounting principles (GAAP), which requires us to make estimates based on assumptions about current, and for some estimates, future, economic and market conditions which affect reported amounts and related disclosures in our financial statements. Although our current estimates contemplate current and expected future conditions, as applicable, it is reasonably possible that actual conditions could differ from our expectations, which could materially affect our results of operations, financial position and cash flows. Such changes could result in future impairments of goodwill, intangibles, long-lived assets, contract assets and investment securities, revisions to estimated profitability on long-term product service and other service agreements, incremental credit losses on receivables and debt securities, incremental losses related to our contingencies, a change in the carrying amount of our tax assets and liabilities, or a change in our insurance liabilities and pension obligations as of the time of a relevant measurement event. In preparing our Statement of Cash Flows, we make certain adjustments to reflect cash flows that cannot otherwise be calculated by changes in our Statement of Financial Position. These adjustments may include, but are not limited to, the effects of currency exchange, acquisitions and dispositions of businesses, businesses classified as held for sale, the timing of settlements to suppliers for property, plant and equipment, non-cash gains/losses and other balance sheet reclassifications. We have reclassified certain prior-year amounts to conform to the current-year’s presentation. Unless otherwise noted, tables are presented in U.S. dollars in millions. Certain columns and rows may not add due to the use of rounded numbers. Percentages presented are calculated from the underlying numbers in millions. Earnings per share amounts are computed independently for earnings from continuing operations, earnings from discontinued operations and net earnings. As a result, the sum of per-share amounts may not equal the total. Unless otherwise indicated, information in these notes to consolidated financial statements relates to continuing operations. Certain of our operations have been presented as discontinued. We present businesses whose disposal represents a strategic shift that has, or will have, a major effect on our operations and financial results as discontinued operations when the components meet the criteria for held for sale, are sold, or spun-off. On April 2, 2024, the Company completed the separation of its GE Vernova business into an independent publicly traded company, GE Vernova, Inc. (GE Vernova). See Note 2 for further information.

BUSINESSES HELD FOR SALE AND DI

BUSINESSES HELD FOR SALE AND DISCONTINUED OPERATIONS	9 Months Ended
	Sep. 30, 2024
Discontinued Operations and Disposal Groups [Abstract]
BUSINESSES HELD FOR SALE AND DISCONTINUED OPERATIONS	BUSINESSES HELD FOR SALE AND DISCONTINUED OPERATIONS. In the fourth quarter of 2022, we classified our captive industrial insurance subsidiary, Electric Insurance Company, domiciled in Massachusetts, into held for sale. In the second quarter of 2024, we completed the sale to Riverstone International Holdings Inc. for cash proceeds of $120 million. In the second quarter of 2024, we classified our non-core licensing business into business held for sale. In the third quarter of 2024, we completed the sale to Dolby Laboratories, Inc. for cash proceeds of $441 million. GE Aerospace will retain intellectual property related to its core aerospace and defense technologies as well as the trademark portfolio for the GE brand. ASSETS AND LIABILITIES OF BUSINESSES HELD FOR SALE September 30, 2024 December 31, 2023 Non-current captive insurance investment securities $ — $ 570 Property, plant and equipment and intangible assets - net — 17 Valuation allowance on disposal group classified as held for sale — (124) All other assets — 77 Assets of businesses held for sale $ — $ 541 Insurance liabilities and annuity benefits $ — $ 376 Accounts payable and other liabilities — 1 Borrowings — — Liabilities of businesses held for sale $ — $ 378 DISCONTINUED OPERATIONS primarily comprise our former GE Vernova and GE HealthCare businesses, our mortgage portfolio in Poland (Bank BPH) and other trailing assets and liabilities associated with prior dispositions. Results of operations, financial position and cash flows for these businesses are reported as discontinued operations for all periods presented and the notes to the financial statements have been adjusted on a retrospective basis. GE Vernova. On April 2, 2024, we completed the previously announced separation of GE Vernova. The separation was structured as a tax-free spin-off and was achieved through the Company's pro-rata distribution of all the outstanding shares of GE Vernova to holders of the Company's common stock. In connection with the GE Vernova separation, the historical results of GE Vernova and certain assets and liabilities included in the separation are reported in GE Aerospace consolidated financial statements as discontinued operations. In addition, the Company contributed $515 million of cash to fund GE Vernova’s future operations such that GE Vernova’s cash balance on the date of separation was $4,242 million. We have continuing involvement with GE Vernova primarily through ongoing sales of products, a transition services agreement, through which GE Aerospace and GE Vernova continue to provide certain services to each other for a period of time following the separation, a separation and distribution agreement, including performance and financial guarantees, a tax matters agreement and a trademark licensing agreement. For the six months (post separation) ended September 30, 2024, we had direct and indirect sales of $146 million to GE Vernova, primarily related to engine sales and parts. We collected net cash of $746 million related to the transition services agreement and sales of engines and parts. GE HealthCare . On January 3, 2023, we completed the previously announced separation of our HealthCare business, into a separate, independent, publicly traded company, GE HealthCare Technologies Inc. (GE HealthCare). The separation was structured as a tax-free spin-off and was achieved through the Company's pro-rata distribution of approximately 80.1% of the outstanding shares of GE HealthCare to holders of the Company's common stock. In connection with the separation, the historical results of GE HealthCare and certain assets and liabilities included in the separation are reported in GE Aerospace consolidated financial statements as discontinued operations. We have continuing involvement with GE HealthCare primarily through a transition services agreement, through which GE Aerospace and GE HealthCare continue to provide certain services to each other for a period of time following the separation, a tax matters agreement and a trademark licensing agreement. For the nine months ended September 30, 2024, we collected net cash of $203 million related to these activities. Bank BPH . As previously reported, Bank BPH, along with other Polish banks, has been subject to ongoing litigation in Poland related to its portfolio of floating rate residential mortgage loans, with cases brought by individual borrowers seeking relief related to their foreign currency indexed or denominated mortgage loans in various courts throughout Poland. As previously reported, a settlement program was adopted and we recorded a charge of $1,014 million in the quarter ended June 30, 2023. The estimate of total losses for borrower litigation at Bank BPH was $2,711 million and $2,669 million as of September 30, 2024 and December 31, 2023, respectively. In order to maintain appropriate regulatory capital levels, during the year ended December 31, 2023, we made the previously reported non-cash capital contributions in the form of intercompany loan forgiveness of $1,797 million; no incremental contributions from GE Aerospace were required during the nine months ended September 30, 2024. For further information about factors that are relevant to the estimate of total losses for borrower litigation at Bank BPH, see Note 22. Future changes or adverse developments could increase our estimate of total losses and potentially require future cash contributions to Bank BPH. The Bank BPH financing receivable portfolio is recorded at the lower of cost or fair value, less cost to sell, which reflects market yields and estimates with respect to ongoing borrower litigation. At September 30, 2024, the total portfolio had no carrying value, net of a valuation allowance. Earnings (loss) related to ongoing borrower litigation were zero in pre-tax charges for both the three and nine months ended September 30, 2024, and zero and $1,189 million in pre-tax charges for the three and nine months ended September 30, 2023, respectively. RESULTS OF DISCONTINUED OPERATIONS Three months ended September 30 2024 2023 GE Vernova GE HealthCare Bank BPH & Other Total GE Vernova GE HealthCare Bank BPH & Other Total Total revenues $ — $ — $ — $ — $ 8,233 $ — $ — $ 8,233 Cost of equipment and services sold — — — — (7,120) — — (7,120) Other income, costs and expenses (1) — 6 5 (1,142) (34) (5) (1,182) Earnings (loss) of discontinued operations before income taxes (1) — 6 5 (29) (34) (5) (68) Benefit (provision) for income taxes 136 — 1 137 (113) 222 (12) 97 Earnings (loss) of discontinued operations, net of taxes 135 — 7 142 (142) 188 (17) 29 Gain (loss) on disposal before income taxes — — 6 6 — — 2 2 Benefit (provision) for income taxes — — (1) (1) — — — — Gain (loss) on disposal, net of taxes — — 6 6 — — 2 2 Earnings (loss) from discontinued operations, net of taxes $ 135 $ — $ 13 $ 147 $ (142) $ 188 $ (15) $ 31 RESULTS OF DISCONTINUED OPERATIONS Nine months ended September 30 2024 2023 GE Vernova GE HealthCare Bank BPH & Other Total GE Vernova GE HealthCare Bank BPH & Other Total Total revenues $ 7,244 $ — $ — $ 7,244 $ 23,156 $ — $ — $ 23,156 Cost of equipment and services sold (6,074) — — (6,074) (19,872) — — (19,872) Other income, costs and expenses (1,300) 11 10 (1,280) (3,861) (54) (1,246) (5,162) Earnings (loss) of discontinued operations before income taxes (130) 11 10 (110) (577) (54) (1,246) (1,877) Benefit (provision) for income taxes 4 (2) 6 8 (250) 1,708 (2) 1,457 Earnings (loss) of discontinued operations, net of taxes (126) 8 16 (102) (827) 1,654 (1,248) (421) Gain (loss) on disposal before income taxes — — 18 18 — — 6 6 Benefit (provision) for income taxes — — (1) (1) — — — — Gain (loss) on disposal, net of taxes — — 17 17 — — 6 6 Earnings (loss) from discontinued operations, net of taxes $ (126) $ 8 $ 33 $ (85) $ (827) $ 1,654 $ (1,242) $ (415) The tax benefit for the nine months ended September 30, 2023 for GE HealthCare relates to preparatory steps for the spin-off, which resulted in taxable gain offset by a deferred tax asset and the reversal of valuation allowances for capital loss carryovers utilized against a portion of the gain. ASSETS AND LIABILITIES OF DISCONTINUED OPERATIONS September 30, 2024 December 31, 2023 Cash, cash equivalents and restricted cash $ 1,468 $ 3,762 Current receivables 13 7,324 Inventories, including deferred inventory costs — 8,245 Goodwill — 4,437 Other intangible assets - net — 1,053 Contract and other deferred assets — 8,959 Property, plant and equipment - net 44 5,306 All other assets 455 5,750 Deferred income taxes 27 3,093 Assets of discontinued operations(a)(b) $ 2,006 $ 47,927 Accounts payable $ 35 $ 8,475 Contract liabilities, progress collections & deferred income — 15,255 Long-term borrowings — 294 Non-current compensation and benefits 35 3,589 All other liabilities(a) 1,258 11,600 Liabilities of discontinued operations(b) $ 1,328 $ 39,213 (a) Included $1,766 million and $1,963 million of valuation allowances against financing receivables held for sale, of which $1,684 million and $1,712 million related to estimated borrower litigation losses, and $1,027 million and $957 million in All other liabilities, related to estimated borrower litigation losses for Bank BPH’s foreign currency-denominated mortgage portfolio, as of September 30, 2024 and December 31, 2023, respectively. Accordingly, total estimated losses related to borrower litigation were $2,711 million and $2,669 million as of September 30, 2024 and December 31, 2023, respectively. As a result of the settlement program, the valuation allowance completely offsets the financing receivables balance as of September 30, 2024 and December 31, 2023. (b) Included $107 million and $46,233 million of assets and $52 million and $38,021 million of liabilities for GE Vernova as of September 30, 2024 and December 31, 2023, respectively.

INVESTMENT SECURITIES

INVESTMENT SECURITIES	9 Months Ended
	Sep. 30, 2024
Investments, Debt and Equity Securities [Abstract]
INVESTMENT SECURITIES	INVESTMENT SECURITIES. The majority of our investment securities are held within our run-off insurance operations and are classified as non-current as they support the long-duration insurance liabilities and include debt securities all classified as available-for-sale, substantially all of which are investment-grade. Our remaining equity shares in GE HealthCare comprised 13.3 million shares (approximately 2.9% ownership interest) at September 30, 2024 and are subject to a contractual lock-up restriction through October 27, 2024. Our senior note from AerCap, for which we have adopted the fair value option and matures in the fourth quarter of 2025, is still outstanding as of September 30, 2024. September 30, 2024 December 31, 2023 Amortized Gross Gross Estimated Amortized Gross Gross Estimated Equity (GE HealthCare) $ — $ — $ — $ 1,246 $ — $ — $ — $ 4,761 Equity note (AerCap) — — — 985 — — — 944 Current investment securities $ — $ — $ — $ 2,232 $ — $ — $ — $ 5,706 Debt U.S. corporate $ 28,192 $ 1,216 $ (1,454) $ 27,954 $ 27,495 $ 1,034 $ (1,606) $ 26,923 Non-U.S. corporate 3,011 53 (197) 2,866 2,529 34 (209) 2,353 State and municipal 2,531 75 (157) 2,449 2,828 79 (185) 2,723 Mortgage and asset-backed 4,991 53 (186) 4,858 4,827 34 (291) 4,571 Government and agencies 1,268 6 (90) 1,184 1,213 3 (116) 1,100 Other equity 203 — — 203 331 — — 331 Non-current investment securities $ 40,196 $ 1,403 $ (2,085) $ 39,514 $ 39,222 $ 1,183 $ (2,406) $ 38,000 The amortized cost of debt securities excludes accrued interest of $499 million and $466 million at September 30, 2024, and December 31, 2023, respectively , which is reported in All other current assets. The estimated fair value of investment securities at September 30, 2024 decreased since December 31, 2023, primarily due to share sales of our GE HealthCare equity interest, partially offset by new investments and higher investment values, due to lower market yields at Insurance and an increase in the mark to market effect on our equity interest in GE HealthCare, due to a higher stock price. Total estimated fair value of debt securities in an unrealized loss position were $17,513 million and $18,730 million, of which $15,056 million and $17,146 million had gross unrealized losses of $(2,016) million and $(2,370) million and had been in a loss position for 12 months or more at September 30, 2024 and December 31, 2023, respectively. Gross unrealized losses at September 30, 2024 included $(123) million related to commercial mortgage-backed securities (CMBS) collateralized by pools of commercial mortgage loans on real estate, and $(61) million related to asset-backed securities. The majority of our CMBS and asset-backed securities in an unrealized loss position have received investment-grade credit ratings from the major rating agencies. The majority of our U.S. and Non-U.S. corporate securities' gross unrealized losses were in the consumer, electric, technology and insurance industries. For our securities in an unrealized loss position, the losses are not indicative of credit losses, we currently do not intend to sell the investments, and it is not more likely than not that we will be required to sell the investments before recovery of their amortized cost basis. Three months ended September 30 Nine months ended September 30 2024 2023 2024 2023 Net unrealized gains (losses) for equity securities with readily determinable fair value (RDFV) $ 245 $ (911) $ 308 $ 5,651 Proceeds from debt/equity securities sales and early redemptions 2,873 3,336 7,109 9,972 Gross realized gains on debt securities 48 7 65 44 Gross realized losses on debt securities (18) (14) (53) (60) Contractual maturities of our debt securities (excluding mortgage and asset-backed securities) at September 30, 2024 are as follows: Amortized cost Estimated fair value Within one year $ 736 $ 734 After one year through five years 4,474 4,589 After five years through ten years 4,995 5,184 After ten years 24,797 23,945 We expect actual maturities to differ from contractual maturities because borrowers have the right to call or prepay certain obligations. The majority of our equity securities are classified within Level 1 and the majority of our debt securities are classified within Level 2, as their valuation is determined based on significant observable inputs. Investments with a fair value of $7,385 million and $6,841 million are classified within Level 3, as significant inputs to their valuation models are unobservable at September 30, 2024 and December 31, 2023, respectively. During the nine months ended September 30, 2024 and 2023 there were no significant transfers into or out of Level 3, respectively. In addition to the equity securities described above, we hold $1,311 million and $974 million of equity securities without RDFV including $1,285 million and $939 million at Insurance at September 30, 2024 and December 31, 2023, respectively, that are classified within non-current All other assets in our Statement of Financial Position. Fair value adjustments, including impairments, recorded in earnings were $37 million and $11 million, and $100 million and $45 million for the three and nine months ended September 30, 2024 and 2023, respectively. These are primarily limited partnership investments in private equity, infrastructure and real estate funds that are measured at net asset value per share (or equivalent) as a practical expedient to estimated fair value and are excluded from the fair value hierarchy.

CURRENT AND LONG-TERM RECEIVABL

CURRENT AND LONG-TERM RECEIVABLES	9 Months Ended
	Sep. 30, 2024
Receivables [Abstract]
CURRENT AND LONG-TERM RECEIVABLES	CURRENT AND LONG-TERM RECEIVABLES CURRENT RECEIVABLES September 30, 2024 December 31, 2023 Customer receivables $ 7,069 $ 6,397 Revenue sharing and other partner receivables(a) 1,201 1,252 Non-income based tax receivables 135 129 Supplier advances 481 401 Receivables from disposed businesses 101 121 Other sundry receivables 113 534 Allowance for credit losses(b) (165) (132) Total current receivables $ 8,936 $ 8,703 (a) Revenue sharing and other partner receivables are primarily amounts due from revenue sharing partners who participate in engine programs by developing and supplying certain engine components through the life of the program or other partners who support our production or aftermarket activities. The revenue sharing partners share in program revenues, receive a share of customer progress payments and share costs related to discounts and warranties. (b) Allowance for credit losses increased primarily due to new provisions of $41 million. Sales of customer receivables. From time to time, the Company sells current or long-term receivables to third parties in response to customer-sponsored requests or programs, to facilitate sales, or for risk mitigation purposes. The Company sold current customer receivables to third parties and subsequently collected $437 million and $491 million in the nine months ended September 30, 2024 a nd 2023, respectively, related primarily to our participation in customer-sponsored supply chain finance programs. Within these programs, primarily in the Commercial Engines & Services business, the Company has no continuing involvement; fees associated with the transferred receivables are covered by the customer and cash is received at the original invoice due date. LONG-TERM RECEIVABLES September 30, 2024 December 31, 2023 Long-term customer receivables $ 143 $ 163 Supplier advances 36 32 Sundry receivables 108 158 Allowance for credit losses (1) (4) Total long-term receivables $ 287 $ 349

INVENTORIES, INCLUDING DEFERRED

INVENTORIES, INCLUDING DEFERRED INVENTORY COSTS	9 Months Ended
	Sep. 30, 2024
Inventory Disclosure [Abstract]
INVENTORIES, INCLUDING DEFERRED INVENTORY COSTS	INVENTORIES, INCLUDING DEFERRED INVENTORY COSTS September 30, 2024 December 31, 2023 Raw materials and work in process $ 7,376 $ 6,531 Finished goods 1,392 1,209 Deferred inventory costs(a) 949 544 Inventories, including deferred inventory costs $ 9,718 $ 8,284

PROPERTY, PLANT AND EQUIPMENT A

PROPERTY, PLANT AND EQUIPMENT AND OPERATING LEASES	9 Months Ended
	Sep. 30, 2024
Property, Plant and Equipment [Abstract]
PROPERTY, PLANT AND EQUIPMENT AND OPERATING LEASES	PROPERTY, PLANT AND EQUIPMENT AND OPERATING LEASES September 30, 2024 December 31, 2023 Original cost $ 15,805 $ 15,338 Less accumulated depreciation and amortization (9,620) (9,252) Right-of-use operating lease assets 1,069 1,160 Property, plant and equipment – net $ 7,254 $ 7,246 Operating Lease Liabilities. Our current operating lease liabilities, included in All other current liabilities All other liabilities

GOODWILL AND OTHER INTANGIBLE A

GOODWILL AND OTHER INTANGIBLE ASSETS	9 Months Ended
	Sep. 30, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
GOODWILL AND OTHER INTANGIBLE ASSETS	GOODWILL AND OTHER INTANGIBLE ASSETS In conjunction with the GE Vernova separation, we changed our segment reporting structure. As a result, all prior period balances for those segments were updated to reflect this change. Commercial Engines & Services Defense & Propulsion Technologies Total Balance at January 1, 2024 $ 6,472 $ 2,476 $ 8,948 Goodwill impairments — (251) (251) Goodwill adjustments(a) 35 22 57 Balance at September 30, 2024 $ 6,507 $ 2,247 $ 8,754 (a) Goodwill adjustments are primarily related to foreign currency exchange. Also in conjunction with the GE Vernova separation, the composition of our reporting units for evaluation of goodwill impairment has changed. As a result, we allocated goodwill among new and realigned reporting units using a relative fair value approach and performed assessments for the new reporting units. We assess the possibility that a reporting unit’s fair value has been reduced below its carrying amount due to the occurrence of events or circumstances between annual impairment testing dates. We performed an interim impairment test at our Colibrium Additive reporting unit within our Defense & Propulsion Technologies segment given declines in the additive manufacturing industry due to slower adoption of technology, which incorporated a combination of income and market valuation approaches. The results of the analysis indicated that the carrying value of the reporting unit was in excess of fair value and therefore we recorded a non-cash impairment loss of $251 million in Goodwill impairments in our Statement of Earnings (Loss). After the impairment charges there is no remaining goodwill in the reporting unit. Colibrium Additive is a critical business for current and future technology at GE Aerospace as we continue to focus on where it can create the most value.

CONTRACT AND OTHER DEFERRED ASS

CONTRACT AND OTHER DEFERRED ASSETS, CONTRACT LIABILITIES AND DEFERRED INCOME & PROGRESS COLLECTIONS	9 Months Ended
	Sep. 30, 2024
Contractors [Abstract]
CONTRACT AND OTHER DEFERRED ASSETS, CONTRACT LIABILITIES AND DEFERRED INCOME & PROGRESS COLLECTIONS	CONTRACT AND OTHER DEFERRED ASSETS, CONTRACT LIABILITIES AND DEFERRED INCOME & PROGRESS COLLECTIONS Contract assets (liabilities) and other deferred assets (income), on a net basis, increased the net liability position by $674 million for the nine months ended September 30, 2024, primarily due to an increase in long-term service agreements liabilities of $842 million, and a decrease in long-term service agreement assets of $120 million, partially offset by an increase in equipment and other service agreements of $129 million and a decrease in current deferred income of $118 million. In aggregate, the net liability for long-term service agreements increased primarily due to billings of $6,445 million and net unfavorable changes in estimated profitability of $141 million, primarily in Commercial Engines & Services, partially offset by revenues recognized of $5,716 million. Revenues recognized for contracts included in a liability position at the beginning of the year were $5,063 million and $4,552 million for the nine months ended September 30, 2024 and 2023, respectively. CONTRACT ASSETS, LIABILITIES AND OTHER DEFERRED ASSETS AND INCOME September 30, 2024 December 31, 2023 Long-term service agreements $ 2,257 $ 2,377 Equipment and other service agreements 627 498 Current contract assets $ 2,884 $ 2,875 Nonrecurring engineering costs(a) $ 2,438 $ 2,444 Customer advances and other(b) 2,386 2,342 Contract and other deferred assets 4,823 4,785 Total contract and other deferred assets $ 7,707 $ 7,660 Long-term service agreement liabilities $ 8,744 $ 7,902 Current deferred income 302 420 Contract liabilities and current deferred income $ 9,047 $ 8,322 Non-current deferred income 972 975 Total contract liabilities and deferred income $ 10,018 $ 9,297 Contract assets (liabilities) and other deferred assets (income) $ (2,311) $ (1,637) (a) Included costs incurred prior to production (such as requisition engineering) for equipment production contracts, primarily within our Defense & Propulsion Technologies segment, which are amortized ratably over each unit produced. We assess the recoverability of these costs and if we determine the costs are no longer probable of recovery, the asset is impaired. (b) Included amounts due from customers within our Commercial Engines & Services segment for the sales of engines, spare parts and services, which we collect through fixed or usage-based billings from the sale of spare parts and servicing of equipment under long-term service agreements. Progress collections increased $301 million in the nine months ended September 30, 2024 primarily due to collections received in excess of settlements at Commercial Engines & Services.

ALL OTHER ASSETS

ALL OTHER ASSETS	9 Months Ended
	Sep. 30, 2024
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
ALL OTHER ASSETS	ALL OTHER ASSETS. All other current assets and All other assets primarily include equity method investments, Insurance cash and cash equivalents, receivables and other investments in our run-off insurance operations, pension surplus and prepaid taxes and other deferred charges. All other non-current assets increased $2,141 million in the nine months ended September 30, 2024, primarily due to an increase in equity method and other investments of $695 million, an increase in Insurance cash and cash equivalents of $596 million, an increase in indemnity assets of $502 million, primarily related to GE Vernova, and an increase in prepaid taxes and deferred charges of $189 million. Insurance cash and cash equivalents was $1,380 million and $784 million at September 30, 2024 and December 31, 2023, respectively.

BORROWINGS

BORROWINGS	9 Months Ended
	Sep. 30, 2024
Debt Disclosure [Abstract]
BORROWINGS	BORROWINGS September 30, 2024 December 31, 2023 Current portion of long-term borrowings Senior notes $ 1,608 $ 1,044 Subordinated notes and other 74 27 Other short-term borrowings — 37 Total short-term borrowings $ 1,681 $ 1,108 Senior notes 16,343 17,509 Subordinated notes 1,413 1,383 Other 484 525 Total long-term borrowings $ 18,240 $ 19,417 Total borrowings $ 19,922 $ 20,525

ACCOUNTS PAYABLE

ACCOUNTS PAYABLE	9 Months Ended
	Sep. 30, 2024
Payables and Accruals [Abstract]
ACCOUNTS PAYABLE	ACCOUNTS PAYABLE September 30, 2024 December 31, 2023 Trade payables $ 5,858 $ 5,290 Supply chain finance programs 1,397 1,472 Sundry payables 573 754 Accounts payable $ 7,829 $ 7,516 We facilitate voluntary supply chain finance programs with third parties, which provide participating suppliers the opportunity to sell their GE Aerospace receivables to third parties at the sole discretion of both the suppliers and the third parties. Total supplier invoices paid through these third-party programs were $2,709 million and $2,342 million for the nine months ended September 30, 2024 and 2023, respectively.

INSURANCE LIABILITIES AND ANNUI

INSURANCE LIABILITIES AND ANNUITY BENEFITS	9 Months Ended
	Sep. 30, 2024
Insurance [Abstract]
INSURANCE LIABILITIES AND ANNUITY BENEFITS	INSURANCE LIABILITIES AND ANNUITY BENEFITS. Insurance liabilities and annuity benefits comprise substantially all obligations to annuitants and insureds in our run-off insurance operations. Our insurance operations (net of eliminations) generated revenues of $899 million and $842 million, profit was $171 million and $99 million and net earnings was $135 million and $77 million for the three months ended September 30, 2024 and 2023, respectively. For the nine months ended September 30, 2024 and 2023, revenues were $2,649 million and $2,480 million, profit was $541 million and $233 million and net earnings was $427 million and $181 million, respectively. These operations were primarily supported by investment securities of $39,103 million and $37,592 million, limited partnerships of $4,030 million and $3,300 million, and a diversified commercial mortgage loan portfolio substantially all collateralized by first liens on U.S. commercial real estate properties of $1,883 million and $1,947 million (net of allowance for credit losses of $45 million and $48 million), as of September 30, 2024 and December 31, 2023, respectively. As of September 30, 2024, the commercial mortgage loan portfolio had two delinquent loans, one non-accrual loan and about one-third of the portfolio was held in the office sector, which had a weighted average loan-to-value ratio of 69%, debt service coverage of 1.8, and no scheduled maturities through 2025. A summary of our insurance liabilities and annuity benefits is presented below. September 30, 2024 Long-term care Structured settlement annuities Life Other contracts Total Future policy benefit reserves $ 26,813 $ 9,093 $ 1,060 $ 363 $ 37,329 Investment contracts — 741 — 672 1,413 Other — — 117 287 405 Total $ 26,813 $ 9,834 $ 1,177 $ 1,322 $ 39,147 December 31, 2023 Future policy benefit reserves $ 26,832 $ 9,357 $ 1,117 $ 382 $ 37,689 Investment contracts — 793 — 742 1,535 Other — — 116 285 400 Total $ 26,832 $ 10,150 $ 1,233 $ 1,409 $ 39,624 The following tables summarize balances of and changes in future policy benefits reserves. September 30, 2024 September 30, 2023 Present value of expected net premiums Long-term care Structured settlement annuities Life Long-term care Structured settlement annuities Life Balance, beginning of year $ 4,063 $ — $ 4,803 $ 4,059 $ — $ 4,828 Beginning balance at locked-in discount rate 3,745 — 4,773 3,958 — 5,210 Effect of changes in cash flow assumptions 387 — (1) (9) — (77) Effect of actual variances from expected experience (26) — (5) (42) — (286) Adjusted beginning of year balance 4,106 — 4,768 3,908 — 4,847 Interest accrual 155 — 134 157 — 148 Net premiums collected (298) — (212) (296) — (220) Effect of foreign currency — — (41) — — 11 Ending balance at locked-in discount rate 3,962 — 4,649 3,768 — 4,786 Effect of changes in discount rate assumptions 355 — (24) 43 — (500) Balance, end of year $ 4,317 $ — $ 4,625 $ 3,811 $ — $ 4,286 Present value of expected future policy benefits Balance, beginning of year $ 30,895 $ 9,357 $ 5,921 $ 28,316 $ 8,860 $ 5,868 Beginning balance at locked-in discount rate 27,144 8,561 5,847 27,026 8,790 6,247 Effect of changes in cash flow assumptions 389 — 24 (41) (16) 49 Effect of actual variances from expected experience 24 (25) (4) (79) 18 (254) Adjusted beginning of year balance 27,557 8,536 5,867 26,906 8,792 6,042 Interest accrual 1,112 332 164 1,091 342 177 Benefit payments (1,079) (493) (329) (947) (511) (396) Effect of foreign currency — — (44) — — 12 Ending balance at locked-in discount rate 27,591 8,374 5,658 27,050 8,623 5,835 Effect of changes in discount rate assumptions 3,540 719 26 562 (89) (509) Balance, end of year $ 31,131 $ 9,093 $ 5,684 $ 27,612 $ 8,534 $ 5,326 Net future policy benefit reserves $ 26,813 $ 9,093 $ 1,060 $ 23,801 $ 8,534 $ 1,040 Less: Reinsurance recoverables, net of allowance for credit losses (185) — (32) (133) — (39) Net future policy benefit reserves, after reinsurance recoverables $ 26,628 $ 9,093 $ 1,028 $ 23,668 $ 8,534 $ 1,001 Weighted-average duration of liability (years)(a) 12.3 10.9 5.6 12.3 10.5 5.3 Weighted-average interest accretion rate 5.6% 5.4% 5.1% 5.5% 5.4% 4.9% Current discount rate 5.0% 4.9% 4.6% 5.8% 5.7% 5.6% Gross premiums or assessments recognized during period $ 359 $ — $ 241 $ 367 $ — $ 251 Expected future gross premiums, undiscounted 7,517 — 12,011 7,522 — 12,387 Expected future gross premiums, discounted(a) 4,938 — 5,576 4,656 — 5,144 Expected future benefit payments, undiscounted 62,798 18,769 10,868 63,406 19,480 11,214 Expected future benefit payments, discounted(a) 31,131 9,093 5,684 27,612 8,534 5,326 (a) Determined using the current discount rate as of September 30, 2024 and 2023. As of September 30, 2024 and 2023, policyholders account balances totaled $1,612 million and $1,838 million, respectively. As our insurance operations are in run-off, changes in policyholder account balances for the nine months ended September 30, 2024 and 2023 are primarily attributed to surrenders, withdrawals, and benefit payments of $323 million and $318 million, partially offset by net additions from separate accounts and interest credited of $206 million and $188 million, respectively. Interest on policyholder account balances is generally credited at minimum guaranteed rates, primarily between 3.0% and 6.0% at both September 30, 2024 and 2023. Our 2024 and 2023 annual reviews of future policy benefit reserves cash flow assumptions resulted in immaterial charges to net earnings, indicating claims experience continues to develop consistently with our models. Included in Insurance losses and annuity benefits in our Statement of Earnings (Loss) for the nine months ended September 30, 2024 and 2023 are unfavorable pre-tax adjustments of $54 million and $90 million, respectively, from updating the net premium ratio (i.e., the percentage of projected gross premiums required to cover expected policy benefits and related expenses) after updating for actual historical experience each quarter and updating of future cash flow assumptions. Included in these amounts for the nine months ended September 30, 2024 and 2023, are unfavorable adjustments of $107 million and $298 million, respectively, due to insufficient gross premiums (i.e., net premium ratio exceeded 100%), related to certain cohorts in our long-term care and life insurance portfolios. These adjustments are primarily attributable to increases in the net premium ratio as a result of updating future cash flow assumptions on cohorts where the beginning of the period net premium ratio exceeded 100%. Following approval of a statutory permitted accounting practice in 2018 by our primary regulator, the Kansas Insurance Department, we have since provided a total of $15,035 million of capital contributions to our run-off insurance subsidiaries, including the final contribution of $1,820 million in the first quarter of 2024. In June 2024, we signed an agreement to exit a block of our life and health insurance business via an assumption reinsurance transaction, pending regulatory approvals and other closing conditions. See Notes 3 and 9 for further information related to our run-off insurance operations.

POSTRETIREMENT BENEFIT PLANS

POSTRETIREMENT BENEFIT PLANS	9 Months Ended
	Sep. 30, 2024
Retirement Benefits [Abstract]
POSTRETIREMENT BENEFIT PLANS	POSTRETIREMENT BENEFIT PLANS. We sponsor a number of pension and retiree health and life insurance benefit plans that we present in three categories; principal pension plans, other pension plans and principal retiree benefit plans. Please refer to Note 13 to the consolidated financial statements of our Annual Report on Form 10-K for the year ended December 31, 2023 for further information. The components of benefit plans cost other than the service cost are included in the caption Non-operating benefit costs in our Statement of Earnings (Loss). PRINCIPAL PENSION PLANS Three months ended September 30 Nine months ended September 30 2024 2023 2024 2023 Service cost for benefits earned $ 16 $ 23 $ 53 $ 68 Prior service cost amortization 1 — 5 — Expected return on plan assets (392) (594) (1,360) (1,782) Interest cost on benefit obligations 317 473 1,085 1,419 Net actuarial gain amortization (105) (180) (362) (539) Net periodic expense (income) $ (163) $ (278) $ (579) $ (834) Less discontinued operations $ — $ (94) $ (88) $ (282) Continuing operations - net periodic expense (income) $ (163) $ (184) $ (491) $ (552) Principal retiree benefit plans income was $22 million and $37 million for the three months ended September 30, 2024 and 2023, respectively, and $79 million and $109 million for the nine months ended September 30, 2024 and 2023, respectively. Principal retiree benefit plans income from continuing operations was $22 million and $65 million for the three and nine months ended September 30, 2024, respectively, and $22 million and $66 million for the three and nine months ended September 30, 2023, respectively. Other pension plans income was $3 million and $32 million for the three months ended September 30, 2024 and 2023, respectively, and $15 million and $91 million for the nine months ended September 30, 2024 and 2023, respectively. Other pension plans income from continuing operations was $3 million and $3 million for the three and nine months ended September 30, 2024, respectively, and $11 million and $31 million for the three and nine months ended September 30, 2023, respectively. We have a defined contribution plan for eligible U.S. employees that provides employer contributions, which were $47 million and $73 million for the three months ended September 30, 2024 and 2023, respectively, and $210 million and $253 million for the nine months ended September 30, 2024 and 2023, respectively. Employer contributions from continuing operations was $47 million and $175 million for the three and nine months ended September 30, 2024, respectively, and $46 million and $156 million for the three and nine months ended September 30, 2023, respectively. We also have deferred incentive compensation plans and deferred salary plans for eligible employees with expenses of $13 million and $15 million for the three months ended September 30, 2024 and 2023, and $34 million and $50 million for the nine months ended September 30, 2024 and 2023, respectively. Deferred compensation expense from continuing operations was $13 million and $27 million for the three and nine months ended September 30, 2024, respectively, and $13 million and $42 million for the three and nine months ended September 30, 2023, respectively.

SALES DISCOUNTS AND ALLOWANCES

SALES DISCOUNTS AND ALLOWANCES & ALL OTHER CURRENT AND NON-CURRENT LIABILITIES	9 Months Ended
	Sep. 30, 2024
Other Liabilities Disclosure [Abstract]
SALES DISCOUNTS AND ALLOWANCES & ALL OTHER CURRENT AND NON-CURRENT LIABILITIES	SALES DISCOUNTS AND ALLOWANCES & ALL OTHER CURRENT AND NON-CURRENT LIABILITIES. Sales discounts and allowances increased $331 million in the nine months ended September 30, 2024, primarily due to higher spare parts shipments in Commercial Engines & Services outpacing payments to customers. All other current liabilities and All other liabilities primarily includes employee compensation and benefits, equipment project and commercial liabilities, income taxes payable and uncertain tax positions, environmental, health and safety remediations, operating lease liabilities (see Note 6) and product warranties (see Note 22). All other current liabilities increased $126 million in the nine months ended September 30, 2024, primarily due to an accrual for shareholder litigation of $363 million and an increase in dividends payable of $214 million, partially offset by a decrease in employee compensation and benefits of $518 million. All other liabilities increased $939 million in the nine months ended September 30, 2024, primarily due to increases in uncertain and other income taxes and related liabilities of $674 million, Environmental, health and safety liabilities of $212 million and indemnity liabilities of $159 million, primarily related to GE Vernova.

INCOME TAXES

INCOME TAXES	9 Months Ended
	Sep. 30, 2024
Income Tax Disclosure [Abstract]
INCOME TAXES	INCOME TAXES. Our effective income tax rate was 10.6% and 5.6% for the nine months ended September 30, 2024 and 2023, respectively. The tax rate for 2024 was reduced compared to the U.S. statutory rate of 21% primarily due to separation income tax benefit associated with an increase in net state deferred tax assets that are likely to be utilized after the spin of GE Vernova, U.S. business tax credit benefits, and gains associated with our retained and sold ownership interests, which we expect to recover without tax. The low tax rate for 2023 was reduced compared to the U.S. statutory rate of 21% primarily due to gains associated with our retained and sold ownership interests, which we expect to recover without tax, U.S. business credits, and net tax benefit related to separation income tax effects including losses on separation-related entity restructuring. The OECD (Organisation for Economic Co-operation and Development) has proposed a global minimum tax of 15% of reported profits (Pillar 2) that has been agreed upon in principle by over 140 countries. During 2023, many countries took steps to incorporate Pillar 2 model rule concepts into their domestic laws. Although the model rules provide a framework for applying the minimum tax, countries may enact Pillar 2 slightly differently than the model rules and on different timelines and may adjust domestic tax incentives in response to Pillar 2. Accordingly, we still are evaluating the potential consequences of Pillar 2 on our longer-term financial position. During 2024, we have incurred insignificant tax expenses in connection with Pillar 2. The Internal Revenue Service (IRS) is currently auditing our consolidated U.S. income tax returns for 2016-2020. The following table presents our net deferred tax assets and net deferred tax liabilities attributable to different tax jurisdictions or different tax paying components. DEFERRED INCOME TAXES September 30, 2024 December 31, 2023 Total assets $ 7,908 $ 7,891 Total liabilities (417) (389) Net deferred income tax asset (liability) $ 7,491 $ 7,502

SHAREHOLDERS' EQUITY

SHAREHOLDERS' EQUITY	9 Months Ended
	Sep. 30, 2024
Equity [Abstract]
SHAREHOLDERS' EQUITY	SHAREHOLDERS’ EQUITY ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) (AOCI) Three months ended September 30 Nine months ended September 30 (Dividends per share in dollars) 2024 2023 2024 2023 Beginning balance $ (1,514) $ (3,409) $ (3,623) $ (5,893) AOCI before reclasses – net of taxes of $(65), $141, $(78) and $123 72 (396) 66 (176) Reclasses from AOCI – net of taxes of $—, $—, $103 and $(626)(a) — — 2,093 2,262 AOCI 72 (396) 2,159 2,085 Less AOCI attributable to noncontrolling interests — 1 (22) (1) Currency translation adjustments AOCI $ (1,442) $ (3,806) $ (1,442) $ (3,806) Beginning balance $ 806 $ 4,041 $ 1,786 $ 6,531 AOCI before reclasses – net of taxes of $(11), $10, $(15) and $9 (34) 19 (117) (24) Reclasses from AOCI – net of taxes of $(31), $(61), $(239) and $(718)(a) (106) (207) (1,010) (2,656) AOCI (140) (188) (1,127) (2,680) Less AOCI attributable to noncontrolling interests — — (7) (2) Benefit plans AOCI $ 666 $ 3,853 $ 666 $ 3,853 Beginning balance $ (1,727) $ (1,696) $ (959) $ (1,927) AOCI before reclasses – net of taxes of $327, $(371), $119 and $(310) 1,268 (1,370) 462 (1,099) Reclasses from AOCI – net of taxes of $—, $(2), $12 and $(5) (36) (8) 13 (49) AOCI 1,232 (1,379) 475 (1,147) Less AOCI attributable to noncontrolling interests — — 12 — Investment securities and cash flow hedges AOCI $ (494) $ (3,075) $ (494) $ (3,075) Beginning balance $ (1,601) $ (2,510) $ (3,354) $ (983) AOCI before reclasses – net of taxes of $(400), $581, $66 and $175 (1,504) 2,187 250 660 AOCI (1,504) 2,187 250 660 Long-duration insurance contracts AOCI $ (3,105) $ (323) $ (3,105) $ (323) AOCI at September 30 $ (4,375) $ (3,351) $ (4,375) $ (3,351) Dividends declared per common share $ 0.28 $ 0.08 $ 0.84 $ 0.24 (a) Includes reclassifications from AOCI related to the separations of GE Vernova and GE HealthCare. In the second quarter of 2024, reclassifications of $1,590 million, net of taxes, included currency translation of $2,174 million and benefit plans of $(584) million, related to GE Vernova. In the first quarter of 2023, reclassifications of $195 million, net of taxes, included currency translation of $2,234 million and benefit plans of $(2,030) million, related to GE HealthCare. Preferred stock . In September 2023, we redeemed the remaining outstanding shares of GE preferred stock. Common stock. GE Aerospace common stock shares outstanding were 1,082,294,004 and 1,088,415,995 at September 30, 2024 and December 31, 2023, respectively. We repurchased 7.9 million shares for $1,311 million and 22.9 million shares for $3,744 million during the three and nine months ended September 30, 2024, respectively. The Company's share repurchase program does not obligate it to acquire any specific number of shares. Under this program, shares may be purchased in the open market, in privately negotiated transactions, under accelerated share repurchase programs or under plans complying with Rules 10b5-1 and 10b-18 under the Securities Exchange Act of 1934, as amended.

EARNINGS PER SHARE INFORMATION

EARNINGS PER SHARE INFORMATION	9 Months Ended
	Sep. 30, 2024
Earnings Per Share [Abstract]
EARNINGS PER SHARE INFORMATION	EARNINGS PER SHARE INFORMATION Three months ended September 30 2024 2023 (Earnings for per-share calculation, shares in millions, per-share amounts in dollars) Diluted Basic Diluted Basic Earnings (loss) from continuing operations $ 1,705 $ 1,705 $ 306 $ 306 Preferred stock dividends and other(a) — — (91) (91) Earnings (loss) from continuing operations attributable to common shareholders 1,705 1,705 215 215 Earnings (loss) from discontinued operations 147 147 46 46 Net earnings (loss) attributable to common shareholders 1,852 1,852 261 261 Shares of common stock outstanding 1,083 1,083 1,088 1,088 Employee compensation-related shares (including stock options) 9 — 11 — Total average equivalent shares 1,093 1,083 1,099 1,088 Earnings (loss) per share from continuing operations $ 1.56 $ 1.57 $ 0.20 $ 0.20 Earnings (loss) per share from discontinued operations 0.13 0.14 0.04 0.04 Net earnings (loss) per share 1.70 1.71 0.24 0.24 Potentially dilutive securities(b) 3 21 Nine months ended September 30 2024 2023 (Earnings for per-share calculation, shares in millions, per-share amounts in dollars) Diluted Basic Diluted Basic Earnings (loss) from continuing operations $ 4,766 $ 4,766 $ 8,261 $ 8,264 Preferred stock dividends and other(a) — — (295) (295) Earnings (loss) from continuing operations attributable to common shareholders 4,766 4,766 7,966 7,969 Earnings (loss) from discontinued operations (108) (108) (371) (371) Net earnings (loss) attributable to common shareholders 4,657 4,657 7,595 7,599 Shares of common stock outstanding 1,087 1,087 1,089 1,089 Employee compensation-related shares (including stock options) 11 — 9 — Total average equivalent shares 1,098 1,087 1,098 1,089 Earnings (loss) per share from continuing operations $ 4.34 $ 4.38 $ 7.25 $ 7.32 Earnings (loss) per share from discontinued operations (0.10) (0.10) (0.34) (0.34) Net earnings (loss) per share 4.24 4.28 6.92 6.98 Potentially dilutive securities(b) 7 29 (a) For the three and nine months ended September 30, 2023, included $(28) million and $(58) million, respectively, related to excise tax on preferred share redemptions. (b) Outstanding stock awards not included in the computation of diluted earnings per share because their effect was antidilutive. Our unvested restricted stock unit awards that contain non-forfeitable rights to dividends or dividend equivalents are considered participating securities and historically have been included in the calculation pursuant to the two-class method. For the three and nine months ended September 30, 2024, such participating securities had an insignificant effect. Effective the second quarter of 2024, the Company calculates earnings per share using the treasury stock method. For the three and nine months ended September 30, 2023, application of two-class method treatment had an insignificant effect.

OTHER INCOME (LOSS)

OTHER INCOME (LOSS)	9 Months Ended
	Sep. 30, 2024
Other Income and Expenses [Abstract]
OTHER INCOME (LOSS)	OTHER INCOME (LOSS) Three months ended September 30 Nine months ended September 30 2024 2023 2024 2023 Investment in GE HealthCare realized and unrealized gain (loss) $ 336 $ (813) $ 555 $ 5,066 Investment in and note with AerCap realized and unrealized gain (loss) 21 (296) 36 81 Investment in Baker Hughes realized and unrealized gain (loss) — — — 10 Gains (losses) on retained and sold ownership interests $ 357 $ (1,109) $ 591 $ 5,157 Other net interest and investment income (loss) 187 163 616 458 Licensing and royalty income 59 36 166 90 Equity method income 28 47 107 104 Purchases and sales of business interests(a) 356 — 377 (107) Other items 35 18 108 53 Total other income (loss) $ 1,021 $ (845) $ 1,965 $ 5,755 (a) Included a pre-tax gain of $341 million related to the sale of our non-core licensing business in Corporate in the three months ended September 30, 2024.

RESTRUCTURING CHARGES AND SEPAR

RESTRUCTURING CHARGES AND SEPARATION COSTS	9 Months Ended
	Sep. 30, 2024
Restructuring and Related Activities [Abstract]
RESTRUCTURING CHARGES AND SEPARATION COSTS	RESTRUCTURING CHARGES AND SEPARATION COSTS RESTRUCTURING AND OTHER CHARGES. This table is inclusive of all restructuring charges in our segments and at Corporate & Other. Separately, in our reported segment results, significant, higher-cost restructuring programs are excluded from measurement of segment operating performance for internal and external purposes; those excluded amounts are reported in Restructuring and other charges for Corporate & Other. Three months ended September 30 Nine months ended September 30 RESTRUCTURING AND OTHER CHARGES 2024 2023 2024 2023 Workforce reductions $ 3 $ 24 $ 110 $ 76 Plant closures & associated costs and other asset write-downs 45 21 70 58 Acquisition/disposition net charges and other 328 3 366 7 $ 376 $ 47 $ 546 $ 141 Cost of equipment/services $ 26 $ 2 $ 27 $ 8 Selling, general and administrative expenses 350 45 519 133 Total restructuring and other charges $ 376 $ 47 $ 546 $ 141 Restructuring and other cash expenditures(a) $ 16 $ 27 $ 115 $ 172 (a) Primarily related to employee severance payments. The restructuring liability as of September 30, 2024 and December 31, 2023 was $258 million and $311 million, respectively. Restructuring and other charges for new and ongoing programs primarily included exit activities announced in the fourth quarter of 2022 reflecting lower Corporate & Other shared-service and footprint needs as a result of the GE HealthCare and GE Vernova spin-offs. Additionally, for the three and nine months ended September 30, 2024, restructuring and other charges included costs of $328 million and $363 million, respectively, for the settlement of the Sjunde AP-Fonden shareholder lawsuit. See Note 22 for additional information. SEPARATION COSTS. In November 2021, the Company announced its plan to form three industry-leading, global public companies focused on the growth sectors of aerospace, healthcare and energy. As discussed in Note 2, we completed this plan with the spin of GE Vernova in the second quarter of 2024. Post-separation, we expect to continue to incur operational and transition costs related to ongoing separation activities. For the three and nine months ended September 30, 2024, we incurred pre-tax separation expense of $74 million and $408 million, and paid $144 million and $716 million in cash, respectively, primarily related to employee costs, professional fees, costs to establish certain stand-alone functions and information technology systems, and other transformation and transaction costs to transition to a stand-alone public company. These costs are presented as separation costs in our Statement of Earnings (Loss). In addition, we recognized $61 million of net tax benefit for the three months ended September 30, 2024, including the tax benefit of losses on separation related entity restructuring and $311 million of net tax benefit for the nine months ended September 30, 2024, including deferred tax benefits associated with state tax attributes and the tax benefit of losses on separation-related entity restructuring. For the three and nine months ended September 30, 2023, we incurred pre-tax separation costs of $147 million and $474 million, recognized $247 million and $244 million of net tax benefit, and paid $127 million and $617 million in cash, respectively, related to separation activities. The pre-tax separation costs specifically identifiable to GE HealthCare and GE Vernova are now reflected in discontinued operations. For the three and nine months ended September 30, 2024, we recognized zero and $10 million in pre-tax income, zero and $2 million of net tax expense, and spent $2 million and $11 million in cash, respectively, related to GE HealthCare. In addition, for the three and nine months ended September 30, 2024, we recognized pre-tax separation costs of $2 million and $99 million, incurred zero and $21 million of net tax benefit and spent $66 million and $187 million in cash, respectively, related to GE Vernova. For the three and nine months ended September 30, 2023, we incurred $2 million and $21 million in pre-tax costs, recognized zero and $5 million of net tax benefits and spent $27 million and $168 million in cash, respectively, related to GE HealthCare. For the three and nine months ended September 30, 2023, we incurred $80 million and $184 million pre-tax separation costs, recognized $32 million and $15 million of net tax benefit and spent $48 million and $135 million in cash, respectively, related to GE Vernova.

FINANCIAL INSTRUMENTS

FINANCIAL INSTRUMENTS	9 Months Ended
	Sep. 30, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract]
FINANCIAL INSTRUMENTS	FINANCIAL INSTRUMENTS. The following table provides information about assets and liabilities not carried at fair value and excludes finance leases, equity securities without readily determinable fair value and non-financial assets and liabilities. Substantially all of these assets are considered to be Level 3 and the vast majority of our liabilities’ fair value are considered Level 2. September 30, 2024 December 31, 2023 Carrying Estimated Carrying Estimated Assets Loans and other receivables $ 2,163 $ 2,122 $ 2,110 $ 2,055 Liabilities Borrowings (Note 10) 19,922 19,847 20,525 20,218 Investment contracts (Note 12) 1,413 1,513 1,535 1,616 Assets and liabilities that are reflected in the accompanying financial statements at fair value are not included in the above disclosures; such items include cash and cash equivalents, investment securities and derivative financial instruments. DERIVATIVES AND HEDGING. Our policy requires that derivatives are used solely for managing risks and not for speculative purposes. We use derivatives to manage currency risks related to foreign exchange, interest rate and currency risk between financial assets and liabilities, and certain equity investments and commodity prices. We use cash flow hedges primarily to reduce or eliminate the effects of foreign exchange rate changes, net investment hedges to hedge investments in foreign operations as well as fair value hedges to hedge the effects of interest rate and currency changes on debt we issued. We also use derivatives not designated as hedges from an accounting standpoint (and therefore we do not apply hedge accounting to the relationship) but otherwise serve the same economic purpose as other hedging arrangements. We use economic hedges when we have exposures to currency exchange risk for which we are unable to meet the requirements for hedge accounting or when changes in the carrying amount of the hedged item are already recorded in earnings in the same period as the derivative making hedge accounting unnecessary. Even though the derivative is an effective economic hedge, there may be a net effect on earnings in each period due to differences in the timing of earnings recognition between the derivative and the hedged item. FAIR VALUE OF DERIVATIVES September 30, 2024 December 31, 2023 Gross Notional All other current assets All other current liabilities Gross Notional All other current assets All other current liabilities Qualifying currency exchange contracts $ 1,388 $ 20 $ 16 $ 1,613 $ 26 $ 22 Non-qualifying currency exchange contracts and other(a) 7,160 355 40 16,277 245 56 Gross derivatives $ 8,549 $ 374 $ 56 $ 17,890 $ 271 $ 78 Netting and credit adjustments $ (40) $ (39) $ (28) $ (26) Net derivatives recognized in statement of financial position $ 334 $ 16 $ 243 $ 53 (a) Gains and (losses) included in our Statement of earnings (loss) are $175 million and $(179) million for the three months and $237 and $(1) million for the nine months ended September 30, 2024 and 2023, respectively, primarily in SG&A, driven by hedges of foreign exchange fluctuation and deferred incentive compensation. These amounts are offset by the remeasurement of the underlying exposure through earnings. FAIR VALUE HEDGES. All the fair value hedges were terminated in 2022 due to exposure management actions. The cumulative net gains related to hedging adjustments of $1,102 million and $1,162 million on discontinued hedges were included primarily in long-term borrowings CASH FLOW HEDGES AND NET INVESTMENT HEDGES Amount of Gain (Loss) Recognized in Other Comprehensive Income (Loss) on Derivatives Amount of Gain (Loss) Reclassified from AOCI into Net Income Three months ended September 30 Nine months ended September 30 Three months ended September 30 Nine months ended September 30 2024 2023 2024 2023 2024 2023 2024 2023 Cash flow hedges(a) $ 17 $ (20) $ (4) $ 17 $ 2 $ 21 $ 14 $ 39 Net investment hedges(b) (258) 174 (108) 41 — — — — (a) Primarily currency exchange contracts, and recognized in Costs of Equipment or Services Sold in the Statement of Earnings (Loss). We expect to reclassify a $22 million gain from AOCI to earnings in the next 12 months contemporaneously with the earnings effects of the related forecasted transactions. (b) The carrying value of foreign currency debt designated as net investment hedges was $5,601 million and $4,726 million at September 30, 2024 and December 31, 2023, respectively. COUNTERPARTY CREDIT RISK. Our exposures to counterparties (including accrued interest) was $334 million and $241 million at September 30, 2024 and December 31, 2023, respectively. Counterparties' exposures to our derivative liability (including accrued interest), was $16 million and $53 million at September 30, 2024 and December 31, 2023, respectively.

VARIABLE INTEREST ENTITIES

VARIABLE INTEREST ENTITIES	9 Months Ended
	Sep. 30, 2024
Variable Interest Entities [Abstract]
VARIABLE INTEREST ENTITIES	VARIABLE INTEREST ENTITIES. In our Statement of Financial Position, we have assets of $138 million and $115 million and liabilities of $129 million and $140 million at September 30, 2024 and December 31, 2023, respectively, in consolidated Variable Interest Entities (VIEs). These VIEs are primarily associated with a legacy business in Corporate & Other and have no features that could expose us to losses that would significantly exceed the difference between the consolidated assets and liabilities.

COMMITMENTS, GUARANTEES, PRODUC

COMMITMENTS, GUARANTEES, PRODUCT WARRANTIES AND OTHER LOSS CONTINGENCIES	9 Months Ended
	Sep. 30, 2024
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS, GUARANTEES, PRODUCT WARRANTIES AND OTHER LOSS CONTINGENCIES	COMMITMENTS, GUARANTEES, PRODUCT WARRANTIES AND OTHER LOSS CONTINGENCIES COMMITMENTS. As of September 30, 2024, we had total investment commitments of $3,686 million, of which $3,530 million are related to investments by our run-off insurance operations in investment securities and other assets. Included within these commitments are obligations to make investments in unconsolidated VIEs of $3,459 million. We also have unfunded lending commitments, primarily for U.S. Tax Equity, of $656 million. Additionally, we have committed to provide financing assistance of $2,676 million for future customer acquisitions of aircraft equipped with our engines. See Note 21 for further information regarding VIEs. GUARANTEES . Credit support and indemnification agreements - Continuing Operations. Following the separation of GE Vernova, we have remaining performance and bank guarantees on behalf of GE Vernova. To support GE Vernova in selling products and services globally, we often entered into contracts on behalf of GE Vernova or issued parent company guarantees or trade finance instruments supporting the performance of what were subsidiary legal entities transacting directly with customers, in addition to providing similar credit support for non-customer related activities of GE Vernova (collectively, "GE Aerospace credit support"). Under the Separation and Distribution Agreement (SDA), GE Vernova is obligated to use reasonable best efforts to replace us as the guarantor on or terminate all such credit support instruments. Until such termination or replacement, in the event of non-fulfillment of contractual obligations by the relevant obligor(s), we could be obligated to make payments under the applicable instruments. Under the SDA, GE Vernova is obligated to reimburse and indemnify us for any such payments. Beginning in 2025, GE Vernova will pay us a quarterly fee based on amounts related to the GE Aerospace credit support. We have recorded a reserve of $162 million for our stand ready to perform obligation. Our maximum aggregate exposure under the GE Aerospace credit support cannot be reasonably estimated given the breadth of the portfolio across each of the GE Vernova businesses except for certain financial guarantees and trade finance instruments with a maximum exposure of approximately $851 million, which are not expected to exceed a year beyond separation. The underlying obligations are predominantly customer contracts that GE Vernova performs in the normal course of its business. We have no known instances historically where payments or performance were required by us under parent company guarantees relating to GE Vernova customer contracts. In connection with the spin-off of GE Vernova, under terms of the SDA, Transition Service Agreement (TSA) and Tax Matters Agreement (TMA), we have an obligation to indemnify GE Vernova for certain of its severance costs, environmental matters and tax matters of $145 million, of which $129 million is reserved. We also have remaining obligations under the TMA with GE HealthCare to indemnify them for certain tax costs and other indemnifications of $25 million which are fully reserved. In addition, we have $188 million of other indemnification commitments, including representations and warranties in sales of business assets, for which we recorded a liability of $63 million. Credit support and indemnification agreements- Discontinued Operations . Following the separation of GE Vernova, we also have performance obligations related to GE Vernova's supply chain finance program and an environmental matter with a maximum aggregate exposure of $842 million. Also, under the SDA, TSA, and TMA agreements we have obligations to indemnify GE Vernova for certain of its technology costs, separation for certain facilities, environmental matters and tax matters of $34 million costs, which are fully reserved. GE Aerospace also has obligations under the TSA and TMA to indemnify GE HealthCare for certain technology and tax costs of $62 million which are fully reserved. We also have provided specific indemnities to other buyers of assets of our business that, in the aggregate, represent a maximum potential claim of $480 million with related reserves of $57 million. PRODUCT WARRANTIES. We provide for estimated product warranty expenses when we sell the related products. Because warranty estimates are forecasts that are based on the best available information, mostly historical claims experience, claims costs may differ from amounts provided. The liability for product warranties was $597 million at September 30, 2024 and $639 million at December 31, 2023. LEGAL MATTERS. The following information supplements and amends the discussion of Legal Matters in Note 24 to the consolidated financial statements in our Annual Report on Form 10-K for the year ended December 31, 2023, Note 23 to the consolidated financial statements in our Quarterly Report on Form 10-Q for the quarter ended March 31, 2024 and Note 22 to the consolidated financial statements in our Quarterly Report on Form 10-Q for the quarter ended June 30, 2024; refer to those discussions for information about previously reported legal matters that are not updated below. In the normal course of our business, we are involved from time to time in various arbitrations, class actions, commercial litigation, investigations and other legal, regulatory or governmental actions, including the significant matters described below that could have a material impact on our results of operations. In many proceedings, including the specific matters described below, it is inherently difficult to determine whether any loss is probable or even reasonably possible or to estimate the size or range of the possible loss, and accruals for legal matters are not recorded until a loss for a particular matter is considered probable and reasonably estimable. Given the nature of legal matters and the complexities involved, it is often difficult to predict and determine a meaningful estimate of loss or range of loss until we know, among other factors, the particular claims involved, the likelihood of success of our defenses to those claims, the damages or other relief sought, how discovery or other procedural considerations will affect the outcome, the settlement posture of other parties and other factors that may have a material effect on the outcome. For these matters, unless otherwise specified, we do not believe it is possible to provide a meaningful estimate of loss at this time. Moreover, it is not uncommon for legal matters to be resolved over many years, during which time relevant developments and new information must be continuously evaluated. Shareholder and related lawsuits. Since November 2017, several putative shareholder class actions under the federal securities laws were filed against GE and certain affiliated individuals and consolidated into a single action currently pending in the U.S. District Court for the Southern District of New York (the Hachem case, also referred to as the Sjunde AP-Fonden case). The complaint against defendants GE and current and former GE executive officers alleged violations of Sections 10(b) and 20(a) and Rule 10b-5 of the Securities Exchange Act of 1934 related to insurance reserves and accounting for long-term service agreements and seeks damages on behalf of shareholders who acquired GE stock between February 27, 2013 and January 23, 2018. GE filed a motion to dismiss in December 2019. In January 2021, the court granted the motion to dismiss as to the majority of the claims. Specifically, the court dismissed all claims related to insurance reserves, as well as all claims related to accounting for long-term service agreements, with the exception of certain claims about historic disclosures related to factoring in the Power business that survive as to GE and its former CFO Jeffrey S. Bornstein. All other individual defendants have been dismissed from the case. In April 2022, the court granted the plaintiffs' motion for class certification for shareholders who acquired stock between February 26, 2016 and January 23, 2018. In September 2022, GE filed a motion for summary judgment on the plaintiffs' remaining claims, which the court denied in September 2023, except as to claims arising from disclosures made between November 2017 and January 2018. In April 2024, the court scheduled a trial date for November 2024. In October 2024, we reached an agreement in principle with the plaintiffs to settle the matter for $362.5 million. Final settlement of the matter is subject to court approval. Since February 2018, multiple shareholder derivative lawsuits were filed against current and former GE executive officers and members of GE’s Board of Directors and GE (as nominal defendant). These lawsuits have alleged violations of securities laws, breaches of fiduciary duties, unjust enrichment, waste of corporate assets, abuse of control and gross mismanagement, although the specific matters underlying the allegations in the lawsuits have varied. Two shareholder derivative lawsuits are currently pending: the Lindsey and Priest/Tola cases, which were filed in New York state court. The allegations in these two cases relate to substantially the same facts as those underlying the Sjunde AP-Fonden case. The plaintiffs seek unspecified damages and improvements in GE’s corporate governance and internal procedures. The Lindsey case has been stayed by agreement of the parties, and GE filed a motion to dismiss the Priest/Tola complaint in March 2021. In August 2024, the plaintiffs in the Priest/Tola case filed an amended consolidated complaint asserting substantially the same claims as in the prior derivative actions, and the Company plans to file a motion to dismiss this amended complaint. Bank BPH . As previously reported, Bank BPH, along with other Polish banks, has been subject to ongoing litigation in Poland related to its portfolio of floating rate residential mortgage loans, with cases brought by individual borrowers seeking relief related to their foreign currency indexed or denominated mortgage loans in various courts throughout Poland. For a number of years, we have observed an increase in the total number of lawsuits being brought against Bank BPH and other banks in Poland by current and former borrowers, and we expect this to continue in future reporting periods. As previously reported, GE and Bank BPH approved the adoption of a settlement program and recorded an additional charge of $1,014 million in the quarter ended June 30, 2023. The estimate of total losses for borrower litigation at Bank BPH was $2,711 million and $2,669 million as of September 30, 2024 and December 31, 2023, respectively. The estimate accounts for the costs of payments to borrowers who we estimate will participate in the settlement program, as well as estimates for the results of litigation with other borrowers, which in either case can exceed the value of the current loan balance, and represents our best estimate of the total losses we expect to incur over time informed by experience since adopting the program. However, there are a number of factors that could affect the estimate in the future; refer to the disclosure about Bank BPH in our Annual Report on Form 10-K for the year ended December 31, 2023. ENVIRONMENTAL, HEALTH AND SAFETY MATTERS . Our operations involve or have involved the use, disposal and cleanup of substances regulated under environmental protection laws, including activities for a variety of matters related to GE businesses that have been discontinued or exited. We record reserves for obligations for ongoing and future environmental remediation activities, such as the Housatonic River cleanup, and for additional liabilities we expect to incur in connection with previously remediated sites, such as natural resource damages for the Hudson River where GE completed dredging in 2019. Additionally, like many other industrial companies, we and our subsidiaries are defendants in various lawsuits related to alleged exposure by workers and others to asbestos or other hazardous materials. Liabilities for environmental remediation and worker exposure claims exclude possible insurance recoveries. It is reasonably possible that our exposure will exceed amounts accrued. However, due to uncertainties about the status of laws, regulations, technology and information related to individual sites and lawsuits, such amounts are not reasonably estimable. Total reserves related to environmental remediation and worker exposure claims were $1,925 million and $1,819 million at September 30, 2024 and December 31, 2023, respectively.

SEGMENT INFORMATION

SEGMENT INFORMATION	9 Months Ended
	Sep. 30, 2024
Segment Reporting [Abstract]
SEGMENT INFORMATION	SEGMENT INFORMATION. On April 2, 2024, and in conjunction with the GE Vernova separation, we implemented an organizational change to align our reportable segments more closely with our business structure. In connection with our segment reporting change, we have recast previously reported amounts across all reportable segments to conform to current segment presentation. We have two reportable segments and three operating segments. Operating segments are aggregated into a reportable segment if the operating segments have similar quantitative economic characteristics and if the operating segments are similar in the following qualitative characteristics: (i) nature of products and services; (ii) nature of production processes; (iii) type or class of customer for their products and services; (iv) methods used to distribute the products or provide services; and (v) if applicable, the nature of the regulatory environment. We have aggregated Defense & Systems and Propulsion & Additive Technology into one reportable segment, Defense & Propulsion Technologies, based on similarity in economic characteristics, other qualitative factors and the objectives and principals of ASC 280, Segment Reporting . This is consistent with how our chief operating decision maker (CODM) allocates resources and makes decisions. Refer to our quarterly report on form 10-Q for the period ended June 30, 2024 for a description of our segments. Refer to our Annual Report on Form 10-K for the year ended December 31, 2023, for further information regarding our determination of segment profit for continuing operations, and for our allocations of corporate costs to our segments. SUMMARY OF REPORTABLE SEGMENTS Three months ended September 30 Nine months ended September 30 2024 2023 2024 2023 Commercial Engines & Services $ 7,003 $ 6,457 $ 19,231 $ 17,426 Defense & Propulsion Technologies 2,243 2,205 6,955 6,546 Total segment revenues 9,246 8,662 26,186 23,972 Corporate & Other 596 640 1,704 1,921 Total revenues $ 9,842 $ 9,302 $ 27,890 $ 25,893 Commercial Engines & Services $ 1,799 $ 1,545 $ 4,897 $ 4,148 Defense & Propulsion Technologies 220 269 820 671 Total segment profit (loss) 2,019 1,814 5,717 4,819 Corporate & Other (73) (1,455) (252) 3,974 Interest and other financial charges (251) (270) (762) (767) Non-operating benefit income (cost) 207 244 628 731 Benefit (provision) for income taxes (198) (26) (567) (493) Preferred stock dividends — (91) — (295) Earnings (loss) from continuing operations attributable to common shareholders 1,705 215 4,766 7,970 Earnings (loss) from discontinued operations attributable to common shareholders 147 46 (108) (371) Net earnings (loss) attributable to common shareholders $ 1,852 $ 261 $ 4,657 $ 7,599 EQUIPMENT & SERVICES REVENUES Three months ended September 30 2024 2023 Equipment Services Total Equipment Services Total Commercial Engines & Services $ 1,686 $ 5,317 $ 7,003 $ 1,604 $ 4,853 $ 6,457 Defense & Propulsion Technologies 936 1,306 2,243 878 1,327 2,205 Total segment revenues $ 2,622 $ 6,623 $ 9,246 $ 2,482 $ 6,180 $ 8,662 Nine months ended September 30 2024 2023 Equipment Services Total Equipment Services Total Commercial Engines & Services $ 4,819 $ 14,412 $ 19,231 $ 4,510 $ 12,916 $ 17,426 Defense & Propulsion Technologies 3,017 3,939 6,955 2,871 3,674 6,546 Total segment revenues $ 7,836 $ 18,351 $ 26,186 $ 7,382 $ 16,590 $ 23,972 REMAINING PERFORMANCE OBLIGATION.

BASIS OF PRESENTATION AND SUM_2

BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	9 Months Ended
	Sep. 30, 2024
Accounting Policies [Abstract]
FINANCIAL STATEMENT PRESENTATION	Our financial statements are prepared in conformity with U.S. generally accepted accounting principles (GAAP), which requires us to make estimates based on assumptions about current, and for some estimates, future, economic and market conditions which affect reported amounts and related disclosures in our financial statements. Although our current estimates contemplate current and expected future conditions, as applicable, it is reasonably possible that actual conditions could differ from our expectations, which could materially affect our results of operations, financial position and cash flows. Such changes could result in future impairments of goodwill, intangibles, long-lived assets, contract assets and investment securities, revisions to estimated profitability on long-term product service and other service agreements, incremental credit losses on receivables and debt securities, incremental losses related to our contingencies, a change in the carrying amount of our tax assets and liabilities, or a change in our insurance liabilities and pension obligations as of the time of a relevant measurement event. In preparing our Statement of Cash Flows, we make certain adjustments to reflect cash flows that cannot otherwise be calculated by changes in our Statement of Financial Position. These adjustments may include, but are not limited to, the effects of currency exchange, acquisitions and dispositions of businesses, businesses classified as held for sale, the timing of settlements to suppliers for property, plant and equipment, non-cash gains/losses and other balance sheet reclassifications.
RECLASSIFICATIONS	We have reclassified certain prior-year amounts to conform to the current-year’s presentation. Unless otherwise noted, tables are presented in U.S. dollars in millions. Certain columns and rows may not add due to the use of rounded numbers. Percentages presented are calculated from the underlying numbers in millions. Earnings per share amounts are computed independently for earnings from continuing operations, earnings from discontinued operations and net earnings. As a result, the sum of per-share amounts may not equal the total. Unless otherwise indicated, information in these notes to consolidated financial statements relates to continuing operations. Certain of our operations have been presented as discontinued. We present businesses whose disposal represents a strategic shift that has, or will have, a major effect on our operations and financial results as discontinued operations when the components meet the criteria for held for sale, are sold, or spun-off. On April 2, 2024, the Company completed the separation of its GE Vernova business into an independent publicly traded company, GE Vernova, Inc. (GE Vernova).

BUSINESSES HELD FOR SALE AND _2

BUSINESSES HELD FOR SALE AND DISCONTINUED OPERATIONS (Tables)	9 Months Ended
	Sep. 30, 2024
Discontinued Operations and Disposal Groups [Abstract]
Schedule of Financial Information for Assets and Liabilities of Businesses Held for Sale	ASSETS AND LIABILITIES OF BUSINESSES HELD FOR SALE September 30, 2024 December 31, 2023 Non-current captive insurance investment securities $ — $ 570 Property, plant and equipment and intangible assets - net — 17 Valuation allowance on disposal group classified as held for sale — (124) All other assets — 77 Assets of businesses held for sale $ — $ 541 Insurance liabilities and annuity benefits $ — $ 376 Accounts payable and other liabilities — 1 Borrowings — — Liabilities of businesses held for sale $ — $ 378
Schedule of Financial Information for Discontinued Operations	RESULTS OF DISCONTINUED OPERATIONS Three months ended September 30 2024 2023 GE Vernova GE HealthCare Bank BPH & Other Total GE Vernova GE HealthCare Bank BPH & Other Total Total revenues $ — $ — $ — $ — $ 8,233 $ — $ — $ 8,233 Cost of equipment and services sold — — — — (7,120) — — (7,120) Other income, costs and expenses (1) — 6 5 (1,142) (34) (5) (1,182) Earnings (loss) of discontinued operations before income taxes (1) — 6 5 (29) (34) (5) (68) Benefit (provision) for income taxes 136 — 1 137 (113) 222 (12) 97 Earnings (loss) of discontinued operations, net of taxes 135 — 7 142 (142) 188 (17) 29 Gain (loss) on disposal before income taxes — — 6 6 — — 2 2 Benefit (provision) for income taxes — — (1) (1) — — — — Gain (loss) on disposal, net of taxes — — 6 6 — — 2 2 Earnings (loss) from discontinued operations, net of taxes $ 135 $ — $ 13 $ 147 $ (142) $ 188 $ (15) $ 31 RESULTS OF DISCONTINUED OPERATIONS Nine months ended September 30 2024 2023 GE Vernova GE HealthCare Bank BPH & Other Total GE Vernova GE HealthCare Bank BPH & Other Total Total revenues $ 7,244 $ — $ — $ 7,244 $ 23,156 $ — $ — $ 23,156 Cost of equipment and services sold (6,074) — — (6,074) (19,872) — — (19,872) Other income, costs and expenses (1,300) 11 10 (1,280) (3,861) (54) (1,246) (5,162) Earnings (loss) of discontinued operations before income taxes (130) 11 10 (110) (577) (54) (1,246) (1,877) Benefit (provision) for income taxes 4 (2) 6 8 (250) 1,708 (2) 1,457 Earnings (loss) of discontinued operations, net of taxes (126) 8 16 (102) (827) 1,654 (1,248) (421) Gain (loss) on disposal before income taxes — — 18 18 — — 6 6 Benefit (provision) for income taxes — — (1) (1) — — — — Gain (loss) on disposal, net of taxes — — 17 17 — — 6 6 Earnings (loss) from discontinued operations, net of taxes $ (126) $ 8 $ 33 $ (85) $ (827) $ 1,654 $ (1,242) $ (415) The tax benefit for the nine months ended September 30, 2023 for GE HealthCare relates to preparatory steps for the spin-off, which resulted in taxable gain offset by a deferred tax asset and the reversal of valuation allowances for capital loss carryovers utilized against a portion of the gain. ASSETS AND LIABILITIES OF DISCONTINUED OPERATIONS September 30, 2024 December 31, 2023 Cash, cash equivalents and restricted cash $ 1,468 $ 3,762 Current receivables 13 7,324 Inventories, including deferred inventory costs — 8,245 Goodwill — 4,437 Other intangible assets - net — 1,053 Contract and other deferred assets — 8,959 Property, plant and equipment - net 44 5,306 All other assets 455 5,750 Deferred income taxes 27 3,093 Assets of discontinued operations(a)(b) $ 2,006 $ 47,927 Accounts payable $ 35 $ 8,475 Contract liabilities, progress collections & deferred income — 15,255 Long-term borrowings — 294 Non-current compensation and benefits 35 3,589 All other liabilities(a) 1,258 11,600 Liabilities of discontinued operations(b) $ 1,328 $ 39,213 (a) Included $1,766 million and $1,963 million of valuation allowances against financing receivables held for sale, of which $1,684 million and $1,712 million related to estimated borrower litigation losses, and $1,027 million and $957 million in All other liabilities, related to estimated borrower litigation losses for Bank BPH’s foreign currency-denominated mortgage portfolio, as of September 30, 2024 and December 31, 2023, respectively. Accordingly, total estimated losses related to borrower litigation were $2,711 million and $2,669 million as of September 30, 2024 and December 31, 2023, respectively. As a result of the settlement program, the valuation allowance completely offsets the financing receivables balance as of September 30, 2024 and December 31, 2023. (b) Included $107 million and $46,233 million of assets and $52 million and $38,021 million of liabilities for GE Vernova as of September 30, 2024 and December 31, 2023, respectively.

INVESTMENT SECURITIES (Tables)

INVESTMENT SECURITIES (Tables)	9 Months Ended
	Sep. 30, 2024
Investments, Debt and Equity Securities [Abstract]
Schedule of Investment Securities	September 30, 2024 December 31, 2023 Amortized Gross Gross Estimated Amortized Gross Gross Estimated Equity (GE HealthCare) $ — $ — $ — $ 1,246 $ — $ — $ — $ 4,761 Equity note (AerCap) — — — 985 — — — 944 Current investment securities $ — $ — $ — $ 2,232 $ — $ — $ — $ 5,706 Debt U.S. corporate $ 28,192 $ 1,216 $ (1,454) $ 27,954 $ 27,495 $ 1,034 $ (1,606) $ 26,923 Non-U.S. corporate 3,011 53 (197) 2,866 2,529 34 (209) 2,353 State and municipal 2,531 75 (157) 2,449 2,828 79 (185) 2,723 Mortgage and asset-backed 4,991 53 (186) 4,858 4,827 34 (291) 4,571 Government and agencies 1,268 6 (90) 1,184 1,213 3 (116) 1,100 Other equity 203 — — 203 331 — — 331 Non-current investment securities $ 40,196 $ 1,403 $ (2,085) $ 39,514 $ 39,222 $ 1,183 $ (2,406) $ 38,000
Realized and Unrealized Gain (Loss) on Securities	Three months ended September 30 Nine months ended September 30 2024 2023 2024 2023 Net unrealized gains (losses) for equity securities with readily determinable fair value (RDFV) $ 245 $ (911) $ 308 $ 5,651 Proceeds from debt/equity securities sales and early redemptions 2,873 3,336 7,109 9,972 Gross realized gains on debt securities 48 7 65 44 Gross realized losses on debt securities (18) (14) (53) (60)
Contractual Maturities of Debt Securities (Excluding Mortgage and Asset-Backed Securities)	Contractual maturities of our debt securities (excluding mortgage and asset-backed securities) at September 30, 2024 are as follows: Amortized cost Estimated fair value Within one year $ 736 $ 734 After one year through five years 4,474 4,589 After five years through ten years 4,995 5,184 After ten years 24,797 23,945

CURRENT AND LONG-TERM RECEIVA_2

CURRENT AND LONG-TERM RECEIVABLES (Tables)	9 Months Ended
	Sep. 30, 2024
Receivables [Abstract]
Schedule of Receivables and Allowance for Credit Losses	CURRENT RECEIVABLES September 30, 2024 December 31, 2023 Customer receivables $ 7,069 $ 6,397 Revenue sharing and other partner receivables(a) 1,201 1,252 Non-income based tax receivables 135 129 Supplier advances 481 401 Receivables from disposed businesses 101 121 Other sundry receivables 113 534 Allowance for credit losses(b) (165) (132) Total current receivables $ 8,936 $ 8,703 (a) Revenue sharing and other partner receivables are primarily amounts due from revenue sharing partners who participate in engine programs by developing and supplying certain engine components through the life of the program or other partners who support our production or aftermarket activities. The revenue sharing partners share in program revenues, receive a share of customer progress payments and share costs related to discounts and warranties. (b) Allowance for credit losses increased primarily due to new provisions of $41 million. LONG-TERM RECEIVABLES September 30, 2024 December 31, 2023 Long-term customer receivables $ 143 $ 163 Supplier advances 36 32 Sundry receivables 108 158 Allowance for credit losses (1) (4) Total long-term receivables $ 287 $ 349

INVENTORIES, INCLUDING DEFERR_2

INVENTORIES, INCLUDING DEFERRED INVENTORY COSTS (Tables)	9 Months Ended
	Sep. 30, 2024
Inventory Disclosure [Abstract]
Schedule of Inventories	September 30, 2024 December 31, 2023 Raw materials and work in process $ 7,376 $ 6,531 Finished goods 1,392 1,209 Deferred inventory costs(a) 949 544 Inventories, including deferred inventory costs $ 9,718 $ 8,284

PROPERTY, PLANT AND EQUIPMENT_2

PROPERTY, PLANT AND EQUIPMENT AND OPERATING LEASES (Tables)	9 Months Ended
	Sep. 30, 2024
Property, Plant and Equipment [Abstract]
Schedule of Property, Plant and Equipment	September 30, 2024 December 31, 2023 Original cost $ 15,805 $ 15,338 Less accumulated depreciation and amortization (9,620) (9,252) Right-of-use operating lease assets 1,069 1,160 Property, plant and equipment – net $ 7,254 $ 7,246

GOODWILL AND OTHER INTANGIBLE_2

GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)	9 Months Ended
	Sep. 30, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Changes in Goodwill Balances	Commercial Engines & Services Defense & Propulsion Technologies Total Balance at January 1, 2024 $ 6,472 $ 2,476 $ 8,948 Goodwill impairments — (251) (251) Goodwill adjustments(a) 35 22 57 Balance at September 30, 2024 $ 6,507 $ 2,247 $ 8,754 (a) Goodwill adjustments are primarily related to foreign currency exchange.

CONTRACT AND OTHER DEFERRED A_2

CONTRACT AND OTHER DEFERRED ASSETS, CONTRACT LIABILITIES AND DEFERRED INCOME & PROGRESS COLLECTIONS (Tables)	9 Months Ended
	Sep. 30, 2024
Contractors [Abstract]
Schedule of Contract Assets, Liabilities and Other Deferred Assets and Income	CONTRACT ASSETS, LIABILITIES AND OTHER DEFERRED ASSETS AND INCOME September 30, 2024 December 31, 2023 Long-term service agreements $ 2,257 $ 2,377 Equipment and other service agreements 627 498 Current contract assets $ 2,884 $ 2,875 Nonrecurring engineering costs(a) $ 2,438 $ 2,444 Customer advances and other(b) 2,386 2,342 Contract and other deferred assets 4,823 4,785 Total contract and other deferred assets $ 7,707 $ 7,660 Long-term service agreement liabilities $ 8,744 $ 7,902 Current deferred income 302 420 Contract liabilities and current deferred income $ 9,047 $ 8,322 Non-current deferred income 972 975 Total contract liabilities and deferred income $ 10,018 $ 9,297 Contract assets (liabilities) and other deferred assets (income) $ (2,311) $ (1,637) (a) Included costs incurred prior to production (such as requisition engineering) for equipment production contracts, primarily within our Defense & Propulsion Technologies segment, which are amortized ratably over each unit produced. We assess the recoverability of these costs and if we determine the costs are no longer probable of recovery, the asset is impaired. (b) Included amounts due from customers within our Commercial Engines & Services segment for the sales of engines, spare parts and services, which we collect through fixed or usage-based billings from the sale of spare parts and servicing of equipment under long-term service agreements.

BORROWINGS (Tables)

BORROWINGS (Tables)	9 Months Ended
	Sep. 30, 2024
Debt Disclosure [Abstract]
Schedule of Borrowings	September 30, 2024 December 31, 2023 Current portion of long-term borrowings Senior notes $ 1,608 $ 1,044 Subordinated notes and other 74 27 Other short-term borrowings — 37 Total short-term borrowings $ 1,681 $ 1,108 Senior notes 16,343 17,509 Subordinated notes 1,413 1,383 Other 484 525 Total long-term borrowings $ 18,240 $ 19,417 Total borrowings $ 19,922 $ 20,525

ACCOUNTS PAYABLE (Tables)

ACCOUNTS PAYABLE (Tables)	9 Months Ended
	Sep. 30, 2024
Payables and Accruals [Abstract]
Schedule of Accounts Payable and Accruals	September 30, 2024 December 31, 2023 Trade payables $ 5,858 $ 5,290 Supply chain finance programs 1,397 1,472 Sundry payables 573 754 Accounts payable $ 7,829 $ 7,516

INSURANCE LIABILITIES AND ANN_2

INSURANCE LIABILITIES AND ANNUITY BENEFITS (Tables)	9 Months Ended
	Sep. 30, 2024
Insurance [Abstract]
Schedule of Insurance and Investment Contract Liabilities	A summary of our insurance liabilities and annuity benefits is presented below. September 30, 2024 Long-term care Structured settlement annuities Life Other contracts Total Future policy benefit reserves $ 26,813 $ 9,093 $ 1,060 $ 363 $ 37,329 Investment contracts — 741 — 672 1,413 Other — — 117 287 405 Total $ 26,813 $ 9,834 $ 1,177 $ 1,322 $ 39,147 December 31, 2023 Future policy benefit reserves $ 26,832 $ 9,357 $ 1,117 $ 382 $ 37,689 Investment contracts — 793 — 742 1,535 Other — — 116 285 400 Total $ 26,832 $ 10,150 $ 1,233 $ 1,409 $ 39,624
Summary of Future Policy Benefits	The following tables summarize balances of and changes in future policy benefits reserves. September 30, 2024 September 30, 2023 Present value of expected net premiums Long-term care Structured settlement annuities Life Long-term care Structured settlement annuities Life Balance, beginning of year $ 4,063 $ — $ 4,803 $ 4,059 $ — $ 4,828 Beginning balance at locked-in discount rate 3,745 — 4,773 3,958 — 5,210 Effect of changes in cash flow assumptions 387 — (1) (9) — (77) Effect of actual variances from expected experience (26) — (5) (42) — (286) Adjusted beginning of year balance 4,106 — 4,768 3,908 — 4,847 Interest accrual 155 — 134 157 — 148 Net premiums collected (298) — (212) (296) — (220) Effect of foreign currency — — (41) — — 11 Ending balance at locked-in discount rate 3,962 — 4,649 3,768 — 4,786 Effect of changes in discount rate assumptions 355 — (24) 43 — (500) Balance, end of year $ 4,317 $ — $ 4,625 $ 3,811 $ — $ 4,286 Present value of expected future policy benefits Balance, beginning of year $ 30,895 $ 9,357 $ 5,921 $ 28,316 $ 8,860 $ 5,868 Beginning balance at locked-in discount rate 27,144 8,561 5,847 27,026 8,790 6,247 Effect of changes in cash flow assumptions 389 — 24 (41) (16) 49 Effect of actual variances from expected experience 24 (25) (4) (79) 18 (254) Adjusted beginning of year balance 27,557 8,536 5,867 26,906 8,792 6,042 Interest accrual 1,112 332 164 1,091 342 177 Benefit payments (1,079) (493) (329) (947) (511) (396) Effect of foreign currency — — (44) — — 12 Ending balance at locked-in discount rate 27,591 8,374 5,658 27,050 8,623 5,835 Effect of changes in discount rate assumptions 3,540 719 26 562 (89) (509) Balance, end of year $ 31,131 $ 9,093 $ 5,684 $ 27,612 $ 8,534 $ 5,326 Net future policy benefit reserves $ 26,813 $ 9,093 $ 1,060 $ 23,801 $ 8,534 $ 1,040 Less: Reinsurance recoverables, net of allowance for credit losses (185) — (32) (133) — (39) Net future policy benefit reserves, after reinsurance recoverables $ 26,628 $ 9,093 $ 1,028 $ 23,668 $ 8,534 $ 1,001 Weighted-average duration of liability (years)(a) 12.3 10.9 5.6 12.3 10.5 5.3 Weighted-average interest accretion rate 5.6% 5.4% 5.1% 5.5% 5.4% 4.9% Current discount rate 5.0% 4.9% 4.6% 5.8% 5.7% 5.6% Gross premiums or assessments recognized during period $ 359 $ — $ 241 $ 367 $ — $ 251 Expected future gross premiums, undiscounted 7,517 — 12,011 7,522 — 12,387 Expected future gross premiums, discounted(a) 4,938 — 5,576 4,656 — 5,144 Expected future benefit payments, undiscounted 62,798 18,769 10,868 63,406 19,480 11,214 Expected future benefit payments, discounted(a) 31,131 9,093 5,684 27,612 8,534 5,326 (a) Determined using the current discount rate as of September 30, 2024 and 2023.

POSTRETIREMENT BENEFIT PLANS (T

POSTRETIREMENT BENEFIT PLANS (Tables)	9 Months Ended
	Sep. 30, 2024
Retirement Benefits [Abstract]
Schedule of Net Benefit Costs	The components of benefit plans cost other than the service cost are included in the caption Non-operating benefit costs in our Statement of Earnings (Loss). PRINCIPAL PENSION PLANS Three months ended September 30 Nine months ended September 30 2024 2023 2024 2023 Service cost for benefits earned $ 16 $ 23 $ 53 $ 68 Prior service cost amortization 1 — 5 — Expected return on plan assets (392) (594) (1,360) (1,782) Interest cost on benefit obligations 317 473 1,085 1,419 Net actuarial gain amortization (105) (180) (362) (539) Net periodic expense (income) $ (163) $ (278) $ (579) $ (834) Less discontinued operations $ — $ (94) $ (88) $ (282) Continuing operations - net periodic expense (income) $ (163) $ (184) $ (491) $ (552)

INCOME TAXES (Tables)

INCOME TAXES (Tables)	9 Months Ended
	Sep. 30, 2024
Income Tax Disclosure [Abstract]
Schedule of Deferred Income Taxes	The following table presents our net deferred tax assets and net deferred tax liabilities attributable to different tax jurisdictions or different tax paying components. DEFERRED INCOME TAXES September 30, 2024 December 31, 2023 Total assets $ 7,908 $ 7,891 Total liabilities (417) (389) Net deferred income tax asset (liability) $ 7,491 $ 7,502

SHAREHOLDERS' EQUITY (Tables)

SHAREHOLDERS' EQUITY (Tables)	9 Months Ended
	Sep. 30, 2024
Equity [Abstract]
Schedule of Shareholders' Equity	ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) (AOCI) Three months ended September 30 Nine months ended September 30 (Dividends per share in dollars) 2024 2023 2024 2023 Beginning balance $ (1,514) $ (3,409) $ (3,623) $ (5,893) AOCI before reclasses – net of taxes of $(65), $141, $(78) and $123 72 (396) 66 (176) Reclasses from AOCI – net of taxes of $—, $—, $103 and $(626)(a) — — 2,093 2,262 AOCI 72 (396) 2,159 2,085 Less AOCI attributable to noncontrolling interests — 1 (22) (1) Currency translation adjustments AOCI $ (1,442) $ (3,806) $ (1,442) $ (3,806) Beginning balance $ 806 $ 4,041 $ 1,786 $ 6,531 AOCI before reclasses – net of taxes of $(11), $10, $(15) and $9 (34) 19 (117) (24) Reclasses from AOCI – net of taxes of $(31), $(61), $(239) and $(718)(a) (106) (207) (1,010) (2,656) AOCI (140) (188) (1,127) (2,680) Less AOCI attributable to noncontrolling interests — — (7) (2) Benefit plans AOCI $ 666 $ 3,853 $ 666 $ 3,853 Beginning balance $ (1,727) $ (1,696) $ (959) $ (1,927) AOCI before reclasses – net of taxes of $327, $(371), $119 and $(310) 1,268 (1,370) 462 (1,099) Reclasses from AOCI – net of taxes of $—, $(2), $12 and $(5) (36) (8) 13 (49) AOCI 1,232 (1,379) 475 (1,147) Less AOCI attributable to noncontrolling interests — — 12 — Investment securities and cash flow hedges AOCI $ (494) $ (3,075) $ (494) $ (3,075) Beginning balance $ (1,601) $ (2,510) $ (3,354) $ (983) AOCI before reclasses – net of taxes of $(400), $581, $66 and $175 (1,504) 2,187 250 660 AOCI (1,504) 2,187 250 660 Long-duration insurance contracts AOCI $ (3,105) $ (323) $ (3,105) $ (323) AOCI at September 30 $ (4,375) $ (3,351) $ (4,375) $ (3,351) Dividends declared per common share $ 0.28 $ 0.08 $ 0.84 $ 0.24 (a) Includes reclassifications from AOCI related to the separations of GE Vernova and GE HealthCare. In the second quarter of 2024, reclassifications of $1,590 million, net of taxes, included currency translation of $2,174 million and benefit plans of $(584) million, related to GE Vernova. In the first quarter of 2023, reclassifications of $195 million, net of taxes, included currency translation of $2,234 million and benefit plans of $(2,030) million, related to GE HealthCare.

EARNINGS PER SHARE INFORMATION

EARNINGS PER SHARE INFORMATION (Tables)	9 Months Ended
	Sep. 30, 2024
Earnings Per Share [Abstract]
Schedule of Earnings Per Share	Three months ended September 30 2024 2023 (Earnings for per-share calculation, shares in millions, per-share amounts in dollars) Diluted Basic Diluted Basic Earnings (loss) from continuing operations $ 1,705 $ 1,705 $ 306 $ 306 Preferred stock dividends and other(a) — — (91) (91) Earnings (loss) from continuing operations attributable to common shareholders 1,705 1,705 215 215 Earnings (loss) from discontinued operations 147 147 46 46 Net earnings (loss) attributable to common shareholders 1,852 1,852 261 261 Shares of common stock outstanding 1,083 1,083 1,088 1,088 Employee compensation-related shares (including stock options) 9 — 11 — Total average equivalent shares 1,093 1,083 1,099 1,088 Earnings (loss) per share from continuing operations $ 1.56 $ 1.57 $ 0.20 $ 0.20 Earnings (loss) per share from discontinued operations 0.13 0.14 0.04 0.04 Net earnings (loss) per share 1.70 1.71 0.24 0.24 Potentially dilutive securities(b) 3 21 Nine months ended September 30 2024 2023 (Earnings for per-share calculation, shares in millions, per-share amounts in dollars) Diluted Basic Diluted Basic Earnings (loss) from continuing operations $ 4,766 $ 4,766 $ 8,261 $ 8,264 Preferred stock dividends and other(a) — — (295) (295) Earnings (loss) from continuing operations attributable to common shareholders 4,766 4,766 7,966 7,969 Earnings (loss) from discontinued operations (108) (108) (371) (371) Net earnings (loss) attributable to common shareholders 4,657 4,657 7,595 7,599 Shares of common stock outstanding 1,087 1,087 1,089 1,089 Employee compensation-related shares (including stock options) 11 — 9 — Total average equivalent shares 1,098 1,087 1,098 1,089 Earnings (loss) per share from continuing operations $ 4.34 $ 4.38 $ 7.25 $ 7.32 Earnings (loss) per share from discontinued operations (0.10) (0.10) (0.34) (0.34) Net earnings (loss) per share 4.24 4.28 6.92 6.98 Potentially dilutive securities(b) 7 29 (a) For the three and nine months ended September 30, 2023, included $(28) million and $(58) million, respectively, related to excise tax on preferred share redemptions. (b) Outstanding stock awards not included in the computation of diluted earnings per share because their effect was antidilutive.

OTHER INCOME (LOSS) (Tables)

OTHER INCOME (LOSS) (Tables)	9 Months Ended
	Sep. 30, 2024
Other Income and Expenses [Abstract]
Schedule of Other Income (Loss)	Three months ended September 30 Nine months ended September 30 2024 2023 2024 2023 Investment in GE HealthCare realized and unrealized gain (loss) $ 336 $ (813) $ 555 $ 5,066 Investment in and note with AerCap realized and unrealized gain (loss) 21 (296) 36 81 Investment in Baker Hughes realized and unrealized gain (loss) — — — 10 Gains (losses) on retained and sold ownership interests $ 357 $ (1,109) $ 591 $ 5,157 Other net interest and investment income (loss) 187 163 616 458 Licensing and royalty income 59 36 166 90 Equity method income 28 47 107 104 Purchases and sales of business interests(a) 356 — 377 (107) Other items 35 18 108 53 Total other income (loss) $ 1,021 $ (845) $ 1,965 $ 5,755 (a) Included a pre-tax gain of $341 million related to the sale of our non-core licensing business in Corporate in the three months ended September 30, 2024.

RESTRUCTURING CHARGES AND SEP_2

RESTRUCTURING CHARGES AND SEPARATION COSTS (Tables)	9 Months Ended
	Sep. 30, 2024
Restructuring and Related Activities [Abstract]
Schedule of Restructuring and Related Costs	This table is inclusive of all restructuring charges in our segments and at Corporate & Other. Separately, in our reported segment results, significant, higher-cost restructuring programs are excluded from measurement of segment operating performance for internal and external purposes; those excluded amounts are reported in Restructuring and other charges for Corporate & Other. Three months ended September 30 Nine months ended September 30 RESTRUCTURING AND OTHER CHARGES 2024 2023 2024 2023 Workforce reductions $ 3 $ 24 $ 110 $ 76 Plant closures & associated costs and other asset write-downs 45 21 70 58 Acquisition/disposition net charges and other 328 3 366 7 $ 376 $ 47 $ 546 $ 141 Cost of equipment/services $ 26 $ 2 $ 27 $ 8 Selling, general and administrative expenses 350 45 519 133 Total restructuring and other charges $ 376 $ 47 $ 546 $ 141 Restructuring and other cash expenditures(a) $ 16 $ 27 $ 115 $ 172 (a) Primarily related to employee severance payments.

FINANCIAL INSTRUMENTS (Tables)

FINANCIAL INSTRUMENTS (Tables)	9 Months Ended
	Sep. 30, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Schedule of Estimated Fair Value of Assets and Liabilities	The following table provides information about assets and liabilities not carried at fair value and excludes finance leases, equity securities without readily determinable fair value and non-financial assets and liabilities. Substantially all of these assets are considered to be Level 3 and the vast majority of our liabilities’ fair value are considered Level 2. September 30, 2024 December 31, 2023 Carrying Estimated Carrying Estimated Assets Loans and other receivables $ 2,163 $ 2,122 $ 2,110 $ 2,055 Liabilities Borrowings (Note 10) 19,922 19,847 20,525 20,218 Investment contracts (Note 12) 1,413 1,513 1,535 1,616
Schedule of Fair Value of Derivative Assets	FAIR VALUE OF DERIVATIVES September 30, 2024 December 31, 2023 Gross Notional All other current assets All other current liabilities Gross Notional All other current assets All other current liabilities Qualifying currency exchange contracts $ 1,388 $ 20 $ 16 $ 1,613 $ 26 $ 22 Non-qualifying currency exchange contracts and other(a) 7,160 355 40 16,277 245 56 Gross derivatives $ 8,549 $ 374 $ 56 $ 17,890 $ 271 $ 78 Netting and credit adjustments $ (40) $ (39) $ (28) $ (26) Net derivatives recognized in statement of financial position $ 334 $ 16 $ 243 $ 53
Schedule of Fair Value of Derivative Liabilities	FAIR VALUE OF DERIVATIVES September 30, 2024 December 31, 2023 Gross Notional All other current assets All other current liabilities Gross Notional All other current assets All other current liabilities Qualifying currency exchange contracts $ 1,388 $ 20 $ 16 $ 1,613 $ 26 $ 22 Non-qualifying currency exchange contracts and other(a) 7,160 355 40 16,277 245 56 Gross derivatives $ 8,549 $ 374 $ 56 $ 17,890 $ 271 $ 78 Netting and credit adjustments $ (40) $ (39) $ (28) $ (26) Net derivatives recognized in statement of financial position $ 334 $ 16 $ 243 $ 53
Schedule of Effects of Derivatives on AOCI	Amount of Gain (Loss) Recognized in Other Comprehensive Income (Loss) on Derivatives Amount of Gain (Loss) Reclassified from AOCI into Net Income Three months ended September 30 Nine months ended September 30 Three months ended September 30 Nine months ended September 30 2024 2023 2024 2023 2024 2023 2024 2023 Cash flow hedges(a) $ 17 $ (20) $ (4) $ 17 $ 2 $ 21 $ 14 $ 39 Net investment hedges(b) (258) 174 (108) 41 — — — — (a) Primarily currency exchange contracts, and recognized in Costs of Equipment or Services Sold in the Statement of Earnings (Loss). We expect to reclassify a $22 million gain from AOCI to earnings in the next 12 months contemporaneously with the earnings effects of the related forecasted transactions.

SEGMENT INFORMATION (Tables)

SEGMENT INFORMATION (Tables)	9 Months Ended
	Sep. 30, 2024
Segment Reporting [Abstract]
Summary of Reportable Segments	SUMMARY OF REPORTABLE SEGMENTS Three months ended September 30 Nine months ended September 30 2024 2023 2024 2023 Commercial Engines & Services $ 7,003 $ 6,457 $ 19,231 $ 17,426 Defense & Propulsion Technologies 2,243 2,205 6,955 6,546 Total segment revenues 9,246 8,662 26,186 23,972 Corporate & Other 596 640 1,704 1,921 Total revenues $ 9,842 $ 9,302 $ 27,890 $ 25,893 Commercial Engines & Services $ 1,799 $ 1,545 $ 4,897 $ 4,148 Defense & Propulsion Technologies 220 269 820 671 Total segment profit (loss) 2,019 1,814 5,717 4,819 Corporate & Other (73) (1,455) (252) 3,974 Interest and other financial charges (251) (270) (762) (767) Non-operating benefit income (cost) 207 244 628 731 Benefit (provision) for income taxes (198) (26) (567) (493) Preferred stock dividends — (91) — (295) Earnings (loss) from continuing operations attributable to common shareholders 1,705 215 4,766 7,970 Earnings (loss) from discontinued operations attributable to common shareholders 147 46 (108) (371) Net earnings (loss) attributable to common shareholders $ 1,852 $ 261 $ 4,657 $ 7,599
Schedule of Equipment and Services Revenues	EQUIPMENT & SERVICES REVENUES Three months ended September 30 2024 2023 Equipment Services Total Equipment Services Total Commercial Engines & Services $ 1,686 $ 5,317 $ 7,003 $ 1,604 $ 4,853 $ 6,457 Defense & Propulsion Technologies 936 1,306 2,243 878 1,327 2,205 Total segment revenues $ 2,622 $ 6,623 $ 9,246 $ 2,482 $ 6,180 $ 8,662 Nine months ended September 30 2024 2023 Equipment Services Total Equipment Services Total Commercial Engines & Services $ 4,819 $ 14,412 $ 19,231 $ 4,510 $ 12,916 $ 17,426 Defense & Propulsion Technologies 3,017 3,939 6,955 2,871 3,674 6,546 Total segment revenues $ 7,836 $ 18,351 $ 26,186 $ 7,382 $ 16,590 $ 23,972

BUSINESSES HELD FOR SALE AND _3

BUSINESSES HELD FOR SALE AND DISCONTINUED OPERATIONS - Assets Held for Sale Narrative (Details) - Disposed of by sale, not discontinued operations - USD ($) $ in Millions	3 Months Ended
	Sep. 30, 2024	Jun. 30, 2024
Riverstone International Holdings Inc
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Proceeds from business dispositions		$ 120
Non-core licensing business
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Proceeds from business dispositions	$ 441

BUSINESSES HELD FOR SALE AND _4

BUSINESSES HELD FOR SALE AND DISCONTINUED OPERATIONS - Financial Information for Assets and Liabilities of Businesses Held for Sale (Details) - Held for sale, not discontinued operation - USD ($) $ in Millions	Sep. 30, 2024	Dec. 31, 2023
Assets
Non-current captive insurance investment securities	$ 0	$ 570
Property, plant and equipment and intangible assets - net	0	17
Valuation allowance on disposal group classified as held for sale	0	(124)
All other assets	0	77
Assets of discontinued operations	0	541
Liabilities
Insurance liabilities and annuity benefits	0	376
Accounts payable and other liabilities	0	1
Borrowings	0	0
Liabilities of discontinued operations	$ 0	$ 378

BUSINESSES HELD FOR SALE AND _5

BUSINESSES HELD FOR SALE AND DISCONTINUED OPERATIONS - Discontinued Operations Narrative (Details) - USD ($)			3 Months Ended			6 Months Ended	9 Months Ended		12 Months Ended
	Apr. 02, 2024	Jan. 03, 2023	Sep. 30, 2024	Sep. 30, 2023	Jun. 30, 2023	Sep. 30, 2024	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023
GE Vernova
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Cash balance	$ 4,242,000,000
Spinoff | GE Vernova
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Cash payments associated with transaction	$ 515,000,000
Discontinued operations after disposal, sales						$ 146,000,000
Discontinued operations after disposal, cash collected (paid)						746,000,000
Spinoff | GE HealthCare
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Discontinued operations after disposal, cash collected (paid)							$ 203,000,000
Ownership interest disposed of		80.10%
Discontinued operations | Bank BPH
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Pre-tax non-cash charges			$ 0	$ 0	$ 1,014,000,000		0	$ 1,189,000,000
Capital contribution, non-cash							0		$ 1,797,000,000
Financing receivables held for sale			0			0	0
Discontinued operations | Bank BPH | Bank BPH litigation
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Estimated borrower litigation losses			$ 2,711,000,000			$ 2,711,000,000	$ 2,711,000,000		$ 2,669,000,000

BUSINESSES HELD FOR SALE AND _6

BUSINESSES HELD FOR SALE AND DISCONTINUED OPERATIONS - Financial Information for Discontinued Operations (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023
RESULTS OF DISCONTINUED OPERATIONS
Earnings (loss) from discontinued operations, net of taxes	$ 147	$ 31	$ (85)	$ (415)
Discontinued operations
RESULTS OF DISCONTINUED OPERATIONS
Total revenues	0	8,233	7,244	23,156
Cost of equipment and services sold	0	(7,120)	(6,074)	(19,872)
Other income, costs and expenses	5	(1,182)	(1,280)	(5,162)
Earnings (loss) of discontinued operations before income taxes	5	(68)	(110)	(1,877)
Benefit (provision) for income taxes	137	97	8	1,457
Earnings (loss) of discontinued operations, net of taxes	142	29	(102)	(421)
Gain (loss) on disposal before income taxes	6	2	18	6
Benefit (provision) for income taxes	(1)	0	(1)	0
Gain (loss) on disposal, net of taxes	6	2	17	6
Earnings (loss) from discontinued operations, net of taxes	147	31	(85)	(415)
Assets
Cash, cash equivalents and restricted cash	1,468		1,468		$ 3,762
Current receivables	13		13		7,324
Inventories, including deferred inventory costs	0		0		8,245
Goodwill	0		0		4,437
Other intangible assets - net	0		0		1,053
Contract and other deferred assets	0		0		8,959
Property, plant and equipment - net	44		44		5,306
All other assets	455		455		5,750
Deferred income taxes	27		27		3,093
Assets of discontinued operations	2,006		2,006		47,927
Liabilities
Accounts payable	35		35		8,475
Contract liabilities, progress collections & deferred income	0		0		15,255
Long-term borrowings	0		0		294
Non-current compensation and benefits	35		35		3,589
All other liabilities	1,258		1,258		11,600
Liabilities of discontinued operations	1,328		1,328		39,213
Discontinued operations | GE Vernova
RESULTS OF DISCONTINUED OPERATIONS
Total revenues	0	8,233	7,244	23,156
Cost of equipment and services sold	0	(7,120)	(6,074)	(19,872)
Other income, costs and expenses	(1)	(1,142)	(1,300)	(3,861)
Earnings (loss) of discontinued operations before income taxes	(1)	(29)	(130)	(577)
Benefit (provision) for income taxes	136	(113)	4	(250)
Earnings (loss) of discontinued operations, net of taxes	135	(142)	(126)	(827)
Gain (loss) on disposal before income taxes	0	0	0	0
Benefit (provision) for income taxes	0	0	0	0
Gain (loss) on disposal, net of taxes	0	0	0	0
Earnings (loss) from discontinued operations, net of taxes	135	(142)	(126)	(827)
Assets
Assets of discontinued operations	107		107		46,233
Liabilities
Liabilities of discontinued operations	52		52		$ 38,021
Discontinued operations | GE HealthCare
RESULTS OF DISCONTINUED OPERATIONS
Total revenues	0	0	0	0
Cost of equipment and services sold	0	0	0	0
Other income, costs and expenses	0	(34)	11	(54)
Earnings (loss) of discontinued operations before income taxes	0	(34)	11	(54)
Benefit (provision) for income taxes	0	222	(2)	1,708
Earnings (loss) of discontinued operations, net of taxes	0	188	8	1,654
Gain (loss) on disposal before income taxes	0	0	0	0
Benefit (provision) for income taxes	0	0	0	0
Gain (loss) on disposal, net of taxes	0	0	0	0
Earnings (loss) from discontinued operations, net of taxes	0	188	8	1,654
Discontinued operations | Bank BPH & Other
RESULTS OF DISCONTINUED OPERATIONS
Total revenues	0	0	0	0
Cost of equipment and services sold	0	0	0	0
Other income, costs and expenses	6	(5)	10	(1,246)
Earnings (loss) of discontinued operations before income taxes	6	(5)	10	(1,246)
Benefit (provision) for income taxes	1	(12)	6	(2)
Earnings (loss) of discontinued operations, net of taxes	7	(17)	16	(1,248)
Gain (loss) on disposal before income taxes	6	2	18	6
Benefit (provision) for income taxes	(1)	0	(1)	0
Gain (loss) on disposal, net of taxes	6	2	17	6
Earnings (loss) from discontinued operations, net of taxes	$ 13	$ (15)	$ 33	$ (1,242)

BUSINESSES HELD FOR SALE AND _7

BUSINESSES HELD FOR SALE AND DISCONTINUED OPERATIONS - Financial Information for Discontinued Operations - Footnote (Details) - Discontinued operations - USD ($) $ in Millions	Sep. 30, 2024	Dec. 31, 2023
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Valuation allowance on finance receivables classified as held for sale	$ 1,766	$ 1,963
All other liabilities	1,258	11,600
Assets of discontinued operations	2,006	47,927
Liabilities of discontinued operations	1,328	39,213
GE Vernova
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Assets of discontinued operations	107	46,233
Liabilities of discontinued operations	52	38,021
Bank BPH | Bank BPH litigation
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Valuation allowance on finance receivables classified as held for sale	1,684	1,712
All other liabilities	1,027	957
Estimated borrower litigation losses	$ 2,711	$ 2,669

INVESTMENT SECURITIES - Narrati

INVESTMENT SECURITIES - Narrative (Details) - USD ($) shares in Millions, $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Accrued interest, current	$ 499		$ 499		$ 466
Accrued interest, current, statement of financial position	All other current assets (Note 9)		All other current assets (Note 9)		All other current assets (Note 9)
Debt securities in unrealized loss position, total	$ 17,513		$ 17,513		$ 18,730
Debt securities in unrealized loss position, 12 months or more	15,056		15,056		17,146
Gross unrealized losses, 12 months or more	(2,016)		(2,016)		(2,370)
Gross unrealized losses	(2,085)		(2,085)		(2,406)
Investments without readily determinable fair value	1,311		1,311		974
Fair value adjustments, including impairment	37	$ 11	100	$ 45
Level 3
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Investment securities with a fair value	7,385		7,385		6,841
CMBS
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Gross unrealized losses	(123)		(123)
Asset-backed securities
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Gross unrealized losses	(61)		(61)
Insurance
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Investments without readily determinable fair value	$ 1,285		$ 1,285		$ 939
GE HealthCare
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Equity securities, remaining interest (in shares)	13.3		13.3
Equity securities, ownership percentage	2.90%		2.90%

INVESTMENT SECURITIES - Schedul

INVESTMENT SECURITIES - Schedule of Investment Securities (Details) - USD ($) $ in Millions	Sep. 30, 2024	Dec. 31, 2023
Debt and Equity Securities, FV-NI [Line Items]
Amortized cost	$ 0	$ 0
Estimated fair value	2,232	5,706
Gross unrealized gains	1,403	1,183
Gross unrealized losses	(2,085)	(2,406)
Other equity	203	331
Non-current investment securities, amortized cost	40,196	39,222
Non-current investment securities, estimated fair value	39,514	38,000
U.S. corporate
Debt and Equity Securities, FV-NI [Line Items]
Amortized cost, excluding accrued interest	28,192	27,495
Gross unrealized gains	1,216	1,034
Gross unrealized losses	(1,454)	(1,606)
Estimated fair value	27,954	26,923
Non-U.S. corporate
Debt and Equity Securities, FV-NI [Line Items]
Amortized cost, excluding accrued interest	3,011	2,529
Gross unrealized gains	53	34
Gross unrealized losses	(197)	(209)
Estimated fair value	2,866	2,353
State and municipal
Debt and Equity Securities, FV-NI [Line Items]
Amortized cost, excluding accrued interest	2,531	2,828
Gross unrealized gains	75	79
Gross unrealized losses	(157)	(185)
Estimated fair value	2,449	2,723
Mortgage and asset-backed
Debt and Equity Securities, FV-NI [Line Items]
Amortized cost, excluding accrued interest	4,991	4,827
Gross unrealized gains	53	34
Gross unrealized losses	(186)	(291)
Estimated fair value	4,858	4,571
Government and agencies
Debt and Equity Securities, FV-NI [Line Items]
Amortized cost, excluding accrued interest	1,268	1,213
Gross unrealized gains	6	3
Gross unrealized losses	(90)	(116)
Estimated fair value	1,184	1,100
GE HealthCare
Debt and Equity Securities, FV-NI [Line Items]
Amortized cost	0	0
Estimated fair value	1,246	4,761
AerCap
Debt and Equity Securities, FV-NI [Line Items]
Amortized cost	0	0
Estimated fair value	$ 985	$ 944

INVESTMENT SECURITIES - Realize

INVESTMENT SECURITIES - Realized and Unrealized Gain (Loss) on Securities (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Investments, Debt and Equity Securities [Abstract]
Net unrealized gains (losses) for equity securities with readily determinable fair value (RDFV)	$ 245	$ (911)	$ 308	$ 5,651
Proceeds from debt/equity securities sales and early redemptions	2,873	3,336	7,109	9,972
Gross realized gains on debt securities	48	7	65	44
Gross realized losses on debt securities	$ (18)	$ (14)	$ (53)	$ (60)

INVESTMENT SECURITIES - Contrac

INVESTMENT SECURITIES - Contractual Maturities (Details) $ in Millions	Sep. 30, 2024 USD ($)
Amortized cost
Within one year	$ 736
After one year through five years	4,474
After five years through ten years	4,995
After ten years	24,797
Estimated fair value
Within one year	734
After one year through five years	4,589
After five years through ten years	5,184
After ten years	$ 23,945

CURRENT AND LONG-TERM RECEIVA_3

CURRENT AND LONG-TERM RECEIVABLES - Schedule of Current Receivables (Details) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2024	Dec. 31, 2023
Receivables [Abstract]
Customer receivables	$ 7,069	$ 6,397
Revenue sharing and other partner receivables	1,201	1,252
Non-income based tax receivables	135	129
Supplier advances	481	401
Receivables from disposed businesses	101	121
Other sundry receivables	113	534
Allowance for credit losses	(165)	(132)
Total current receivables	8,936	$ 8,703
New provisions	$ 41

CURRENT AND LONG-TERM RECEIVA_4

CURRENT AND LONG-TERM RECEIVABLES - Narrative (Details) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Receivables [Abstract]
Sale of current customer receivables	$ 437	$ 491

CURRENT AND LONG-TERM RECEIVA_5

CURRENT AND LONG-TERM RECEIVABLES - Schedule of Long-term Receivables (Details) - USD ($) $ in Millions	Sep. 30, 2024	Dec. 31, 2023
Receivables [Abstract]
Long-term customer receivables	$ 143	$ 163
Supplier advances	36	32
Sundry receivables	108	158
Allowance for credit losses	(1)	(4)
Total long-term receivables	$ 287	$ 349

INVENTORIES, INCLUDING DEFERR_3

INVENTORIES, INCLUDING DEFERRED INVENTORY COSTS (Details) - USD ($) $ in Millions	Sep. 30, 2024	Dec. 31, 2023
Inventory Disclosure [Abstract]
Raw materials and work in process	$ 7,376	$ 6,531
Finished goods	1,392	1,209
Deferred inventory costs	949	544
Inventories, including deferred inventory costs	$ 9,718	$ 8,284

PROPERTY, PLANT AND EQUIPMENT_3

PROPERTY, PLANT AND EQUIPMENT AND OPERATING LEASES - Schedule of Property, Plant and Equipment (Details) - USD ($) $ in Millions	Sep. 30, 2024	Dec. 31, 2023
Property, Plant and Equipment [Abstract]
Original cost	$ 15,805	$ 15,338
Less accumulated depreciation and amortization	(9,620)	(9,252)
Right-of-use operating lease assets	1,069	1,160
Property, plant and equipment – net	$ 7,254	$ 7,246
Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]	Property, plant and equipment – net	Property, plant and equipment – net

PROPERTY, PLANT AND EQUIPMENT_4

PROPERTY, PLANT AND EQUIPMENT AND OPERATING LEASES - Narrative (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023
Property, Plant and Equipment [Abstract]
Operating lease liabilities, current	$ 293		$ 293		$ 308
Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]	All other current liabilities (Note 14)		All other current liabilities (Note 14)		All other current liabilities (Note 14)
Operating lease liabilities, noncurrent	$ 842		$ 842		$ 931
Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]	All other liabilities (Note 14)		All other liabilities (Note 14)		All other liabilities (Note 14)
Long-term (fixed) expense	$ 120	$ 122	$ 360	$ 367

GOODWILL AND OTHER INTANGIBLE_3

GOODWILL AND OTHER INTANGIBLE ASSETS - Changes in Goodwill Balances (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Goodwill
Balance at beginning of period			$ 8,948
Goodwill impairments	$ (251)	$ 0	(251)	$ 0
Goodwill adjustments			57
Balance at end of period	8,754		8,754
Operating segments | Commercial Engines & Services
Goodwill
Balance at beginning of period			6,472
Goodwill impairments			0
Goodwill adjustments			35
Balance at end of period	6,507		6,507
Operating segments | Defense & Propulsion Technologies
Goodwill
Balance at beginning of period			2,476
Goodwill impairments			(251)
Goodwill adjustments			22
Balance at end of period	$ 2,247		$ 2,247

GOODWILL AND OTHER INTANGIBLE_4

GOODWILL AND OTHER INTANGIBLE ASSETS - Narrative (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Goodwill [Line Items]
Goodwill impairments	$ 251	$ 0	$ 251	$ 0
Increase (decrease) in intangible assets			(271)
Amortization of intangible assets	$ 89	$ 94	261	$ 278
Operating segments | Defense & Propulsion Technologies
Goodwill [Line Items]
Goodwill impairments			251
Operating segments | Defense & Propulsion Technologies | Colibrium Additive reporting unit
Goodwill [Line Items]
Goodwill impairments			$ 251

CONTRACT AND OTHER DEFERRED A_3

CONTRACT AND OTHER DEFERRED ASSETS, CONTRACT LIABILITIES AND DEFERRED INCOME & PROGRESS COLLECTIONS - Narrative (Details) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Capitalized Contract Cost [Line Items]
Contract assets (liabilities) and other deferred assets (income), increase net liability position	$ 674
Increase (decrease) in long-term service agreement liabilities	842
Increase (decrease) in long-term service agreement assets	(120)
Increase (decrease) in equipment and other service agreements	129
Increase (decrease) in current deferred income	(118)
Revenue recognized, contract liability	5,063	$ 4,552
Increase in progress collections and deferred income due to timing of revenue recognition	301
Long-term
Capitalized Contract Cost [Line Items]
Increase (decrease) due to billings	6,445
Net favorable (unfavorable) change in estimated profitability	(141)
Revenues recognized, contract asset	$ 5,716

CONTRACT AND OTHER DEFERRED A_4

CONTRACT AND OTHER DEFERRED ASSETS, CONTRACT LIABILITIES AND DEFERRED INCOME & PROGRESS COLLECTIONS - Schedule of Contract Assets, Liabilities and Other Deferred Assets and Income (Details) - USD ($) $ in Millions	Sep. 30, 2024	Dec. 31, 2023
Contractors [Abstract]
Long-term service agreements	$ 2,257	$ 2,377
Equipment and other service agreements	627	498
Current contract assets	2,884	2,875
Nonrecurring engineering costs	2,438	2,444
Customer advances and other	2,386	2,342
Contract and other deferred assets	4,823	4,785
Total contract and other deferred assets	7,707	7,660
Long-term service agreement liabilities	8,744	7,902
Current deferred income	302	420
Contract liabilities and current deferred income	9,047	8,322
Non-current deferred income	972	975
Total contract liabilities and deferred income	10,018	9,297
Contract assets (liabilities) and other deferred assets (income)	$ (2,311)	$ (1,637)

ALL OTHER ASSETS (Details)

ALL OTHER ASSETS (Details) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2024	Dec. 31, 2023
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
Increase (decrease) in other non-current assets	$ 2,141
Increase (decrease) in equity method and other investments	695
Increase (decrease) in insurance cash and cash equivalents	596
Increase (decrease) in indemnity assets	502
Increase (decrease) in prepaid taxes and deferred charges	189
Insurance cash and cash equivalents	$ 1,380	$ 784

BORROWINGS (Details)

BORROWINGS (Details) - USD ($) $ in Millions	Sep. 30, 2024	Dec. 31, 2023
Debt Instrument [Line Items]
Total short-term borrowings	$ 1,681	$ 1,108
Long-term borrowings and lease obligation	18,240	19,417
Total borrowings	19,922	20,525
Senior notes
Debt Instrument [Line Items]
Long-term borrowings	16,343	17,509
Subordinated notes and other
Debt Instrument [Line Items]
Long-term borrowings	1,413	1,383
Other
Debt Instrument [Line Items]
Long-term borrowings and lease obligation	484	525
Senior notes
Debt Instrument [Line Items]
Current portion of long-term borrowings	1,608	1,044
Subordinated notes and other
Debt Instrument [Line Items]
Current portion of long-term borrowings	74	27
Other short-term borrowings
Debt Instrument [Line Items]
Other short-term borrowings	$ 0	$ 37

ACCOUNTS PAYABLE - Schedule of

ACCOUNTS PAYABLE - Schedule of Accounts Payable and Accruals (Details) - USD ($) $ in Millions	Sep. 30, 2024	Dec. 31, 2023
Payables and Accruals [Abstract]
Trade payables	$ 5,858	$ 5,290
Supply chain finance programs	1,397	1,472
Sundry payables	573	754
Accounts Payable and Other Accrued Liabilities, Current	$ 7,829	$ 7,516

ACCOUNTS PAYABLE - Narrative (D

ACCOUNTS PAYABLE - Narrative (Details) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Payables and Accruals [Abstract]
Supplier finance program, invoices paid	$ 2,709	$ 2,342

INSURANCE LIABILITIES AND ANN_3

INSURANCE LIABILITIES AND ANNUITY BENEFITS - Narrative (Details) $ in Millions	3 Months Ended			9 Months Ended		69 Months Ended
	Sep. 30, 2024 USD ($) loan	Mar. 31, 2024 USD ($)	Sep. 30, 2023 USD ($)	Sep. 30, 2024 USD ($) loan	Sep. 30, 2023 USD ($)	Sep. 30, 2024 USD ($) loan	Dec. 31, 2023 USD ($)
Disaggregation of Revenue [Line Items]
Insurance revenues	$ 899		$ 842	$ 2,649	$ 2,480
Net earnings (loss)	$ 1,842		338	$ 4,676	7,857
Percent of portfolio held in office sector	33.30%			33.30%		33.30%
Policyholder account balance	$ 1,612		$ 1,838	$ 1,612	1,838	$ 1,612
Policyholder account balance, surrender, withdrawal and benefit payments				323	318
Policyholder account balance, net additions and interest credited				$ 206	$ 188
Policyholder account balance, crediting rate	3%		6%	3%	6%	3%
Net premium ratio update, favorable (unfavorable) adjustment				$ (54)	$ (90)
Insufficient gross premiums adjustment				107	298
Capital contributions to insurance subsidiaries		$ 1,820				$ 15,035
Run-off Insurance operations
Disaggregation of Revenue [Line Items]
Insurance revenues	$ 899		$ 842	2,649	2,480
Gross profit (loss)	171		99	541	233
Net earnings (loss)	135		$ 77	427	$ 181
Investment securities	39,103			39,103		39,103	$ 37,592
Limited partnerships	4,030			4,030		4,030	3,300
Run-off Insurance operations | CMBS
Disaggregation of Revenue [Line Items]
Estimated fair value	1,883			1,883		1,883	1,947
Debt securities, allowance for credit losses	$ 45			$ 45		$ 45	$ 48
Number of delinquent loans | loan	2			2		2
Number of nonaccrual loans | loan	1			1		1
Weighted average loan to value ratio	69%			69%		69%
Debt service coverage ratio	1.8			1.8		1.8

INSURANCE LIABILITIES AND ANN_4

INSURANCE LIABILITIES AND ANNUITY BENEFITS - Schedule of Investment Contracts, Insurance Liabilities and Insurance Annuity Benefits (Details) - USD ($) $ in Millions	Sep. 30, 2024	Dec. 31, 2023	Sep. 30, 2023
Liability for Claims and Claims Adjustment Expense [Line Items]
Future policy benefit reserves	$ 37,329	$ 37,689
Investment contracts	1,413	1,535
Other	405	400
Total	39,147	39,624
Long-term care
Liability for Claims and Claims Adjustment Expense [Line Items]
Future policy benefit reserves	26,813	26,832	$ 23,801
Investment contracts	0	0
Other	0	0
Total	26,813	26,832
Structured settlement annuities
Liability for Claims and Claims Adjustment Expense [Line Items]
Future policy benefit reserves	9,093	9,357	8,534
Investment contracts	741	793
Other	0	0
Total	9,834	10,150
Life
Liability for Claims and Claims Adjustment Expense [Line Items]
Future policy benefit reserves	1,060	1,117	$ 1,040
Investment contracts	0	0
Other	117	116
Total	1,177	1,233
Other contracts
Liability for Claims and Claims Adjustment Expense [Line Items]
Future policy benefit reserves	363	382
Investment contracts	672	742
Other	287	285
Total	$ 1,322	$ 1,409

INSURANCE LIABILITIES AND ANN_5

INSURANCE LIABILITIES AND ANNUITY BENEFITS - Changes in Future Policy Benefit Reserves (Details) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023	Dec. 31, 2022
Present value of expected future policy benefits
Future policy benefit reserves	$ 37,329		$ 37,689
Long-term care
Present value of expected net premiums
Balance, beginning of year	4,063	$ 4,059
Beginning balance at locked-in discount rate	3,745	3,958
Effect of changes in cash flow assumptions			387	$ (9)
Effect of actual variances from expected experience			(26)	(42)
Adjusted beginning of year balance			4,106	3,908
Interest accrual	155	157
Net premiums collected	(298)	(296)
Effect of foreign currency	0	0
Ending balance at locked-in discount rate	3,962	3,768
Effect of changes in discount rate assumptions	355	43
Balance, end of year	4,317	3,811
Present value of expected future policy benefits
Balance, beginning of year	30,895	28,316
Beginning balance at locked-in discount rate	27,591	27,050	27,144	27,026
Effect of changes in cash flow assumptions			389	(41)
Effect of actual variances from expected experience			24	(79)
Adjusted beginning of year balance			27,557	26,906
Interest accrual	1,112	1,091
Benefit payments	(1,079)	(947)
Effect of foreign currency	0	0
Ending balance at locked-in discount rate	27,591	27,050
Effect of changes in discount rate assumptions	3,540	562
Balance, end of year	31,131	27,612
Future policy benefit reserves	26,813	23,801	26,832
Less: Reinsurance recoverables, net of allowance for credit losses	(185)	(133)
Net future policy benefit reserves, after reinsurance recoverables	$ 26,628	$ 23,668
Weighted-average duration of liability (years)	12 years 3 months 18 days	12 years 3 months 18 days
Weighted-average interest accretion rate	5.60%	5.50%
Current discount rate	5%	5.80%
Gross premiums or assessments recognized during period	$ 359	$ 367
Expected future gross premiums, undiscounted	7,517	7,522
Expected future gross premiums, discounted	4,938	4,656
Expected future benefit payments, undiscounted	62,798	63,406
Expected future benefit payments, discounted	31,131	27,612
Structured settlement annuities
Present value of expected net premiums
Balance, beginning of year	0	0
Beginning balance at locked-in discount rate	0	0
Effect of changes in cash flow assumptions			0	0
Effect of actual variances from expected experience			0	0
Adjusted beginning of year balance			0	0
Interest accrual	0	0
Net premiums collected	0	0
Effect of foreign currency	0	0
Ending balance at locked-in discount rate	0	0
Effect of changes in discount rate assumptions	0	0
Balance, end of year	0	0
Present value of expected future policy benefits
Balance, beginning of year	9,357	8,860
Beginning balance at locked-in discount rate	8,374	8,623	8,561	8,790
Effect of changes in cash flow assumptions			0	(16)
Effect of actual variances from expected experience			(25)	18
Adjusted beginning of year balance			8,536	8,792
Interest accrual	332	342
Benefit payments	(493)	(511)
Effect of foreign currency	0	0
Ending balance at locked-in discount rate	8,374	8,623
Effect of changes in discount rate assumptions	719	(89)
Balance, end of year	9,093	8,534
Future policy benefit reserves	9,093	8,534	9,357
Less: Reinsurance recoverables, net of allowance for credit losses	0	0
Net future policy benefit reserves, after reinsurance recoverables	$ 9,093	$ 8,534
Weighted-average duration of liability (years)	10 years 10 months 24 days	10 years 6 months
Weighted-average interest accretion rate	5.40%	5.40%
Current discount rate	4.90%	5.70%
Gross premiums or assessments recognized during period	$ 0	$ 0
Expected future gross premiums, undiscounted	0	0
Expected future gross premiums, discounted	0	0
Expected future benefit payments, undiscounted	18,769	19,480
Expected future benefit payments, discounted	9,093	8,534
Life
Present value of expected net premiums
Balance, beginning of year	4,803	4,828
Beginning balance at locked-in discount rate	4,773	5,210
Effect of changes in cash flow assumptions			(1)	(77)
Effect of actual variances from expected experience			(5)	(286)
Adjusted beginning of year balance			4,768	4,847
Interest accrual	134	148
Net premiums collected	(212)	(220)
Effect of foreign currency	(41)	11
Ending balance at locked-in discount rate	4,649	4,786
Effect of changes in discount rate assumptions	(24)	(500)
Balance, end of year	4,625	4,286
Present value of expected future policy benefits
Balance, beginning of year	5,921	5,868
Beginning balance at locked-in discount rate	5,658	5,835	5,847	6,247
Effect of changes in cash flow assumptions			24	49
Effect of actual variances from expected experience			(4)	(254)
Adjusted beginning of year balance			5,867	$ 6,042
Interest accrual	164	177
Benefit payments	(329)	(396)
Effect of foreign currency	(44)	12
Ending balance at locked-in discount rate	5,658	5,835
Effect of changes in discount rate assumptions	26	(509)
Balance, end of year	5,684	5,326
Future policy benefit reserves	1,060	1,040	$ 1,117
Less: Reinsurance recoverables, net of allowance for credit losses	(32)	(39)
Net future policy benefit reserves, after reinsurance recoverables	$ 1,028	$ 1,001
Weighted-average duration of liability (years)	5 years 7 months 6 days	5 years 3 months 18 days
Weighted-average interest accretion rate	5.10%	4.90%
Current discount rate	4.60%	5.60%
Gross premiums or assessments recognized during period	$ 241	$ 251
Expected future gross premiums, undiscounted	12,011	12,387
Expected future gross premiums, discounted	5,576	5,144
Expected future benefit payments, undiscounted	10,868	11,214
Expected future benefit payments, discounted	$ 5,684	$ 5,326

POSTRETIREMENT BENEFIT PLANS -

POSTRETIREMENT BENEFIT PLANS - Narrative (Details) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024 USD ($) category	Sep. 30, 2023 USD ($)	Sep. 30, 2024 USD ($) category	Sep. 30, 2023 USD ($)
Defined Benefit Plan Disclosure [Line Items]
Number of categories | category	3		3
Defined contribution plan costs	$ 47	$ 73	$ 210	$ 253
Deferred compensation expense	13	15	34	50
Continuing operations
Defined Benefit Plan Disclosure [Line Items]
Defined contribution plan costs	47	46	175	156
Deferred compensation expense	13	13	27	42
Principal retiree benefit plans
Defined Benefit Plan Disclosure [Line Items]
Plans cost (income)	(22)	(37)	(79)	(109)
Principal retiree benefit plans | Continuing operations
Defined Benefit Plan Disclosure [Line Items]
Plans cost (income)	(22)	(22)	(65)	(66)
Other pension plans
Defined Benefit Plan Disclosure [Line Items]
Plans cost (income)	(3)	(32)	(15)	(91)
Other pension plans | Continuing operations
Defined Benefit Plan Disclosure [Line Items]
Plans cost (income)	$ (3)	$ (11)	$ (3)	$ (31)

POSTRETIREMENT BENEFIT PLANS _2

POSTRETIREMENT BENEFIT PLANS - Effect on Operations of Pension Plans (Details) - Principal pension plans - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Defined Benefit Plan Disclosure [Line Items]
Service cost for benefits earned	$ 16	$ 23	$ 53	$ 68
Prior service cost amortization	1	0	5	0
Expected return on plan assets	(392)	(594)	(1,360)	(1,782)
Interest cost on benefit obligations	317	473	1,085	1,419
Net actuarial gain amortization	(105)	(180)	(362)	(539)
Net periodic expense (income)	(163)	(278)	(579)	(834)
Discontinued operations
Defined Benefit Plan Disclosure [Line Items]
Net periodic expense (income)	0	(94)	(88)	(282)
Continuing operations
Defined Benefit Plan Disclosure [Line Items]
Net periodic expense (income)	$ (163)	$ (184)	$ (491)	$ (552)

SALES DISCOUNTS AND ALLOWANCE_2

SALES DISCOUNTS AND ALLOWANCES & ALL OTHER CURRENT AND NON-CURRENT LIABILITIES (Details) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Other Liabilities Disclosure [Abstract]
Increase (decrease) in sales discounts and allowances	$ 331	$ (147)
Increase (decrease) in other current liabilities	126
Increase (decrease) in shareholder litigation accrual	363
Increase (decrease) in dividends payable	214
Increase (decrease) in employee compensation and benefit liabilities	(518)
Increase (decrease) in other noncurrent liabilities	939
Increase (decrease) in uncertain and other income taxes and related liabilities	674
Increase (decrease) in environmental, health and safety liabilities, noncurrent	212
Increase (decrease) in indemnity liabilities	$ 159

INCOME TAXES - Narrative (Detai

INCOME TAXES - Narrative (Details)	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Income Tax Disclosure [Abstract]
Effective income tax rate	10.60%	5.60%

INCOME TAXES - Deferred Income

INCOME TAXES - Deferred Income Taxes (Details) - USD ($) $ in Millions	Sep. 30, 2024	Dec. 31, 2023
Income Tax Disclosure [Abstract]
Total assets	$ 7,908	$ 7,891
Total liabilities	(417)	(389)
Net deferred income tax asset (liability)	$ 7,491	$ 7,502

SHAREHOLDERS' EQUITY - Schedule

SHAREHOLDERS' EQUITY - Schedule of Shareholders' Equity (Details) - USD ($) $ / shares in Units, $ in Millions	3 Months Ended				9 Months Ended
	Sep. 30, 2024	Jun. 30, 2024	Sep. 30, 2023	Mar. 31, 2023	Sep. 30, 2024	Sep. 30, 2023
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax
Beginning balance					$ 28,605
Ending balance	$ 19,102		$ 29,860		$ 19,102	$ 29,860
Dividends declared per common share (in dollars per share)	$ 0.28		$ 0.08		$ 0.84	$ 0.24
GE Vernova
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax
Reclass from AOCI, net of taxes		$ 1,590
GE HealthCare
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax
Reclass from AOCI, net of taxes				$ 195
Accumulated other comprehensive income (loss)
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax
Beginning balance	$ (4,035)		$ (3,573)	(2,272)	$ (6,150)	$ (2,272)
Ending balance	(4,375)	(4,035)	(3,351)		(4,375)	(3,351)
Currency translation adjustments, including noncontrolling interests
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax
Beginning balance	(1,514)		(3,409)	(5,893)	(3,623)	(5,893)
AOCI before reclass, net of taxes	72		(396)		66	(176)
Reclass from AOCI, net of taxes	0		0		2,093	2,262
Other comprehensive income (loss)	72		(396)		2,159	2,085
Ending balance		(1,514)
AOCI before reclasses, taxes	(65)		141		(78)	123
Reclass from AOCI, taxes	0		0		103	(626)
Currency translation adjustments, including noncontrolling interests | GE Vernova
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax
Reclass from AOCI, net of taxes		2,174
Currency translation adjustments, including noncontrolling interests | GE HealthCare
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax
Reclass from AOCI, net of taxes				2,234
Currency translation adjustments, attributable to noncontrolling interests
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax
Other comprehensive income (loss)	0		1		(22)	(1)
Currency translation adjustments
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax
Other comprehensive income (loss)	72		(397)		2,181	2,086
Ending balance	(1,442)		(3,806)		(1,442)	(3,806)
Benefit plans, including noncontrolling interests
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax
Beginning balance	806		4,041	6,531	1,786	6,531
AOCI before reclass, net of taxes	(34)		19		(117)	(24)
Reclass from AOCI, net of taxes	(106)		(207)		(1,010)	(2,656)
Other comprehensive income (loss)	(140)		(188)		(1,127)	(2,680)
Ending balance		806
AOCI before reclasses, taxes	(11)		10		(15)	9
Reclass from AOCI, taxes	(31)		(61)		(239)	(718)
Benefit plans, including noncontrolling interests | GE Vernova
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax
Reclass from AOCI, net of taxes		(584)
Benefit plans, including noncontrolling interests | GE HealthCare
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax
Reclass from AOCI, net of taxes				(2,030)
Benefit plans, attributable to noncontrolling interests
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax
Other comprehensive income (loss)	0		0		(7)	(2)
Benefit plans AOCI
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax
Other comprehensive income (loss)	(140)		(188)		(1,120)	(2,678)
Ending balance	666		3,853		666	3,853
Investment securities and cash flow hedges, including noncontrolling interests
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax
Beginning balance	(1,727)		(1,696)	(1,927)	(959)	(1,927)
AOCI before reclass, net of taxes	1,268		(1,370)		462	(1,099)
Reclass from AOCI, net of taxes	(36)		(8)		13	(49)
Other comprehensive income (loss)	1,232		(1,379)		475	(1,147)
Ending balance		(1,727)
AOCI before reclasses, taxes	327		(371)		119	(310)
Reclass from AOCI, taxes	0		(2)		12	(5)
Investment securities and cash flow hedges, attributable to noncontrolling interests
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax
Other comprehensive income (loss)	0		0		12	0
Investment securities and cash flow hedges AOCI
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax
Other comprehensive income (loss)	1,232		(1,379)		465	(1,147)
Ending balance	(494)		(3,075)		(494)	(3,075)
Long-duration insurance contracts
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax
Beginning balance	(1,601)		(2,510)	$ (983)	(3,354)	(983)
AOCI before reclass, net of taxes	(1,504)		2,187		250	660
Other comprehensive income (loss)	(1,504)		2,187		250	660
Ending balance	(3,105)	$ (1,601)	(323)		(3,105)	(323)
AOCI before reclasses, taxes	$ (400)		$ 581		$ 66	$ 175

SHAREHOLDERS' EQUITY - Narrativ

SHAREHOLDERS' EQUITY - Narrative (Details) - USD ($) $ in Millions	3 Months Ended	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2024	Dec. 31, 2023
Equity [Abstract]
Common stock, shares outstanding	1,082,294,004	1,082,294,004	1,088,415,995
Stock repurchased (in shares)	7,900,000	22,900,000
Stock repurchased	$ 1,311	$ 3,744

EARNINGS PER SHARE INFORMATIO_2

EARNINGS PER SHARE INFORMATION (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Diluted
Earnings (loss) from continuing operations	$ 1,705	$ 306	$ 4,766	$ 8,261
Preferred stock dividends and other	0	(91)	0	(295)
Earnings (loss) from continuing operations attributable to common shareholders	1,705	215	4,766	7,966
Earnings (loss) from discontinued operations	147	46	(108)	(371)
Net earnings (loss) attributable to common shareholders	$ 1,852	$ 261	$ 4,657	$ 7,595
Total average equivalent shares (in shares)	1,083	1,088	1,087	1,089
Employee compensation-related shares (including stock options) (in shares)	9	11	11	9
Total average equivalent shares (in shares)	1,093	1,099	1,098	1,098
Earnings (loss) per share from continuing operations (in dollars per share)	$ 1.56	$ 0.20	$ 4.34	$ 7.25
Earnings (loss) per share from discontinued operations (in dollars per share)	0.13	0.04	(0.10)	(0.34)
Net earnings (loss) per share (in dollars per share)	$ 1.70	$ 0.24	$ 4.24	$ 6.92
Potentially dilutive securities (in shares)	3	21	7	29
Basic
Earnings (loss) from continuing operations	$ 1,705	$ 306	$ 4,766	$ 8,264
Preferred stock dividends and other	0	(91)	0	(295)
Earnings (loss) from continuing operations attributable to common shareholders	1,705	215	4,766	7,969
Earnings (loss) from discontinued operations	147	46	(108)	(371)
Net earnings (loss) attributable to common shareholders	$ 1,852	$ 261	$ 4,657	$ 7,599
Earnings (loss) per share from continuing operations (in dollars per share)	$ 1.57	$ 0.20	$ 4.38	$ 7.32
Earnings (loss) per share from discontinued operations (in dollars per share)	0.14	0.04	(0.10)	(0.34)
Net earnings (loss) per share (in dollars per share)	$ 1.71	$ 0.24	$ 4.28	$ 6.98
Preferred share redemption
Preferred share redemption, excise tax		$ (28)		$ (58)

OTHER INCOME (LOSS) - Schedule

OTHER INCOME (LOSS) - Schedule of Other Income (Loss) (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Realized and unrealized gain (loss)			$ 723	$ 5,185
Other net interest and investment income (loss)	$ 187	$ 163	616	458
Licensing and royalty income	59	36	166	90
Purchases and sales of business interests	356	0	377	(107)
Other items	35	18	108	53
Total other income (loss)	1,021	(845)	1,965	$ 5,755
Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal, Statement of Income or Comprehensive Income [Extensible Enumeration]				Total other income (loss)
Disposed of by sale, not discontinued operations | Non-core licensing business
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Pre-tax gain (loss) on sale	341
Other (income) loss
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Equity method income	28	47	107	$ 104
Retained and sold ownership interests
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Realized and unrealized gain (loss)	357	(1,109)	591	5,157
GE HealthCare
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Realized and unrealized gain (loss)	336	(813)	555	5,066
AerCap
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Realized and unrealized gain (loss)	21	(296)	36	81
Baker Hughes
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Realized and unrealized gain (loss)	$ 0	$ 0	$ 0	$ 10

OTHER INCOME (LOSS) - Narrative

OTHER INCOME (LOSS) - Narrative (Details) - GE HealthCare shares in Millions, $ in Millions	9 Months Ended
	Sep. 30, 2024 USD ($) shares
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Equity securities, remaining interest (in shares)	13.3
Equity securities, ownership percentage	2.90%
Dispositions of retained ownership interests, proceeds | $	$ 4,071
Dispositions of retained ownership interests, shares sold (in shares)	48.3

RESTRUCTURING CHARGES AND SEP_3

RESTRUCTURING CHARGES AND SEPARATION COSTS - Schedule of Restructuring and Other Charges (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Restructuring Cost and Reserve [Line Items]
Total restructuring and other charges	$ 376	$ 47	$ 546	$ 141
Restructuring and other cash expenditures	16	27	115	172
Cost of equipment/services
Restructuring Cost and Reserve [Line Items]
Total restructuring and other charges	26	2	27	8
Selling, general and administrative expenses
Restructuring Cost and Reserve [Line Items]
Total restructuring and other charges	350	45	519	133
Workforce reductions
Restructuring Cost and Reserve [Line Items]
Total restructuring and other charges	3	24	110	76
Plant closures & associated costs and other asset write-downs
Restructuring Cost and Reserve [Line Items]
Total restructuring and other charges	45	21	70	58
Acquisition/disposition net charges and other(a)
Restructuring Cost and Reserve [Line Items]
Total restructuring and other charges	$ 328	$ 3	$ 366	$ 7

RESTRUCTURING CHARGES AND SEP_4

RESTRUCTURING CHARGES AND SEPARATION COSTS - Narrative (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023
Restructuring Cost and Reserve [Line Items]
Restructuring liability	$ 258		$ 258		$ 311
Litigation settlement costs	328		363
Separation costs (income)	74	$ 147	408	$ 474
Separation costs
Restructuring Cost and Reserve [Line Items]
Separation costs (income)	74	147	408	474
Payments for restructuring costs	144	127	716	617
Restructuring, incurred net tax expense (benefit)	(61)	(247)	(311)	244
Separation costs | Discontinued operations | GE HealthCare
Restructuring Cost and Reserve [Line Items]
Separation costs (income)	0	2	(10)	21
Payments for restructuring costs	2	27	11	168
Restructuring, incurred net tax expense (benefit)	0	0	2	(5)
Separation costs | Discontinued operations | GE Vernova
Restructuring Cost and Reserve [Line Items]
Separation costs (income)	2	80	99	184
Payments for restructuring costs	66	48	187	135
Restructuring, incurred net tax expense (benefit)	$ 0	$ (32)	$ (21)	$ 15

FINANCIAL INSTRUMENTS - Assets

FINANCIAL INSTRUMENTS - Assets and Liabilities Not Carried at Fair Value (Details) - USD ($) $ in Millions	Sep. 30, 2024	Dec. 31, 2023
Liabilities
Investment contracts	$ 1,413	$ 1,535
Carrying amount (net)
Assets
Loans and other receivables	2,163	2,110
Liabilities
Borrowings	19,922	20,525
Investment contracts	1,413	1,535
Estimated fair value
Assets
Loans and other receivables	2,122	2,055
Liabilities
Borrowings	19,847	20,218
Investment contracts	$ 1,513	$ 1,616

FINANCIAL INSTRUMENTS - Fair Va

FINANCIAL INSTRUMENTS - Fair Value of Derivatives (Details) - USD ($) $ in Millions	Sep. 30, 2024	Dec. 31, 2023
Derivative [Line Items]
Gross Notional	$ 8,549	$ 17,890
All other current assets
Derivative asset, statement of financial position	All other current assets (Note 9)	All other current assets (Note 9)
Gross derivatives	$ 374	$ 271
Netting and credit adjustments	(40)	(28)
Net derivatives in statement of financial position	$ 334	$ 243
All other current liabilities
Derivative liability, statement of financial position	All other current liabilities (Note 14)	All other current liabilities (Note 14)
Gross derivatives	$ 56	$ 78
Netting and credit adjustments	(39)	(26)
Net derivatives recognized in statement of financial position	16	53
Qualifying currency exchange contracts
Derivative [Line Items]
Gross Notional	1,388	1,613
All other current assets
Gross derivatives	20	26
All other current liabilities
Gross derivatives	16	22
Non-qualifying currency exchange contracts and other
Derivative [Line Items]
Gross Notional	7,160	16,277
All other current assets
Gross derivatives	355	245
All other current liabilities
Gross derivatives	$ 40	$ 56

FINANCIAL INSTRUMENTS - Fair _2

FINANCIAL INSTRUMENTS - Fair Value of Derivatives, Footnote (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Non-qualifying currency exchange contracts and other
Derivative [Line Items]
Gain (loss) on derivatives	$ 175	$ (179)	$ 237	$ (1)

FINANCIAL INSTRUMENTS - Fair _3

FINANCIAL INSTRUMENTS - Fair Value Hedges, Narrative (Details) - USD ($) $ in Millions	Sep. 30, 2024	Dec. 31, 2023
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Cumulative gain of fair value hedging adjustments	$ 1,102	$ 1,162
Cumulative gain of fair value hedging on discontinued hedging relationships	1,102	1,162
Hedged liability	$ 8,761	$ 9,253
Hedged Liability, Statement of Financial Position [Extensible Enumeration]	Long-term borrowings (Note 10)	Long-term borrowings (Note 10)

FINANCIAL INSTRUMENTS - Cash Fl

FINANCIAL INSTRUMENTS - Cash Flow Hedges and Net Investment (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Gain (loss) recognized in OCI, cash flow hedges	$ 17	$ (20)	$ (4)	$ 17
Gain (loss) recognized in OCI, net investment hedges	(258)	174	(108)	41
Reclassified from AOCI into net income, cash flow hedges	2	21	14	39
Reclassified from AOCI into net income, investment hedges	$ 0	$ 0	0	$ 0
Gain expected to be reclassified to earnings in next 12 months			$ 22

FINANCIAL INSTRUMENTS - Cash _2

FINANCIAL INSTRUMENTS - Cash Flow Hedges and Net Investment, Footnote (Details) - USD ($) $ in Millions	Sep. 30, 2024	Dec. 31, 2023
Foreign currency debt
Derivative [Line Items]
Carrying value designated as net investment hedges	$ 5,601	$ 4,726

FINANCIAL INSTRUMENTS - Counter

FINANCIAL INSTRUMENTS - Counterparty Credit Risk, Narrative (Details) - Counterparty credit risk - USD ($) $ in Millions	Sep. 30, 2024	Dec. 31, 2023
Derivative [Line Items]
Exposure to counterparties (including accrued interest)	$ 334	$ 241
Net amount	$ 16	$ 53

VARIABLE INTEREST ENTITIES (Det

VARIABLE INTEREST ENTITIES (Details) - USD ($) $ in Millions	Sep. 30, 2024	Dec. 31, 2023
Variable Interest Entity [Line Items]
Assets	$ 126,698	$ 173,300
Liabilities	107,595	144,695
Consolidated VIE
Variable Interest Entity [Line Items]
Assets	138	115
Liabilities	129	140
Unconsolidated VIEs
Variable Interest Entity [Line Items]
Assets	7,586	6,577
Unconsolidated VIEs | U.S. Tax Equity Investments
Variable Interest Entity [Line Items]
Assets	1,158	1,205
Unconsolidated VIEs | Insurance
Variable Interest Entity [Line Items]
Assets	$ 6,244	$ 5,145

COMMITMENTS, GUARANTEES, PROD_2

COMMITMENTS, GUARANTEES, PRODUCT WARRANTIES AND OTHER LOSS CONTINGENCIES - Commitments (Details) $ in Millions	Sep. 30, 2024 USD ($)
Investment commitments
Long-term Purchase Commitment [Line Items]
Commitments	$ 3,686
Run-off Insurance operations
Long-term Purchase Commitment [Line Items]
Commitments	3,530
Run-off insurance operations, unconsolidated VIE investment commitment
Long-term Purchase Commitment [Line Items]
Commitments	3,459
Unfunded lending commitments
Long-term Purchase Commitment [Line Items]
Commitments	656
Financial assistance
Long-term Purchase Commitment [Line Items]
Commitments	$ 2,676

COMMITMENTS, GUARANTEES, PROD_3

COMMITMENTS, GUARANTEES, PRODUCT WARRANTIES AND OTHER LOSS CONTINGENCIES - Guarantees (Details) $ in Millions	Sep. 30, 2024 USD ($)
Credit support agreement | GE Vernova | Continuing operations
Guarantor Obligations [Line Items]
Guarantee obligations, reserve	$ 162
Financial guarantee | GE Vernova | Continuing operations
Guarantor Obligations [Line Items]
Maximum exposure	851
Indemnification agreement, SDA, TSA and TMA | GE Vernova | Continuing operations
Guarantor Obligations [Line Items]
Maximum exposure	145
Guarantee obligations, reserve	129
Indemnification agreement, SDA, TSA and TMA | GE Vernova | Discontinued operations
Guarantor Obligations [Line Items]
Maximum exposure	34
Indemnification agreement, TMA | GE HealthCare | Continuing operations
Guarantor Obligations [Line Items]
Guarantee obligations, liability	25
Other indemnification agreements | Continuing operations
Guarantor Obligations [Line Items]
Maximum exposure	188
Guarantee obligations, liability	63
Other indemnification agreements | Discontinued operations
Guarantor Obligations [Line Items]
Maximum exposure	480
Guarantee obligations, reserve	57
Performance obligation | GE Vernova | Discontinued operations
Guarantor Obligations [Line Items]
Maximum exposure	842
Indemnification agreement, TSA and TMA | GE HealthCare | Discontinued operations
Guarantor Obligations [Line Items]
Guarantee obligations, liability	$ 62

COMMITMENTS, GUARANTEES, PROD_4

COMMITMENTS, GUARANTEES, PRODUCT WARRANTIES AND OTHER LOSS CONTINGENCIES - Product Warranties (Details) - USD ($) $ in Millions	Sep. 30, 2024	Dec. 31, 2023
Commitments and Contingencies Disclosure [Abstract]
Liability for product warranties	$ 597	$ 639

COMMITMENTS, GUARANTEES, PROD_5

COMMITMENTS, GUARANTEES, PRODUCT WARRANTIES AND OTHER LOSS CONTINGENCIES - Shareholder and Related Lawsuits (Details) $ in Millions	1 Months Ended
	Oct. 22, 2024 USD ($)	Feb. 28, 2018 lawsuit
Shareholder class action lawsuits | Subsequent event
Loss Contingencies [Line Items]
Settlement, amount awarded to other party | $	$ 362.5
Lindsey and Priest/Tola cases
Loss Contingencies [Line Items]
Number of lawsuits | lawsuit		2

COMMITMENTS, GUARANTEES, PROD_6

COMMITMENTS, GUARANTEES, PRODUCT WARRANTIES AND OTHER LOSS CONTINGENCIES - Bank BPH (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Jun. 30, 2023	Sep. 30, 2024	Dec. 31, 2023
Related Party Transaction [Line Items]
Litigation settlement costs	$ 328		$ 363
Bank BPH | Bank BPH litigation
Related Party Transaction [Line Items]
Litigation settlement costs		$ 1,014
Estimate loss	$ 2,711		$ 2,711	$ 2,669

COMMITMENTS, GUARANTEES, PROD_7

COMMITMENTS, GUARANTEES, PRODUCT WARRANTIES AND OTHER LOSS CONTINGENCIES - Environmental, Health and Safety Matters (Details) - USD ($) $ in Millions	Sep. 30, 2024	Dec. 31, 2023
Commitments and Contingencies Disclosure [Abstract]
Total reserves related to environmental remediation and worker exposure claims	$ 1,925	$ 1,819

SEGMENT INFORMATION - Narrative

SEGMENT INFORMATION - Narrative (Details) $ in Millions	9 Months Ended
	Sep. 30, 2024 USD ($) segment
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Number of reportable segments | segment	2
Number of operating segments | segment	3
Performance obligations expected to be satisfied	$ 166,089
Equipment
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Performance obligations expected to be satisfied	$ 19,210
Equipment | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-10-01 | Performance obligation satisfaction, period one
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Performance obligation expected to be satisfied (as a percent)	28%
Performance obligations expected to be satisfied, expected timing	1 year
Equipment | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-10-01 | Performance obligation satisfaction, period two
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Performance obligation expected to be satisfied (as a percent)	43%
Performance obligations expected to be satisfied, expected timing	2 years
Equipment | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-10-01 | Performance obligation satisfaction, period three
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Performance obligation expected to be satisfied (as a percent)	71%
Performance obligations expected to be satisfied, expected timing	5 years
Services
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Performance obligations expected to be satisfied	$ 146,879
Services | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-10-01 | Performance obligation satisfaction, period one
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Performance obligation expected to be satisfied (as a percent)	10%
Performance obligations expected to be satisfied, expected timing	1 year
Services | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-10-01 | Performance obligation satisfaction, period two
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Performance obligation expected to be satisfied (as a percent)	41%
Performance obligations expected to be satisfied, expected timing	5 years
Services | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-10-01 | Performance obligation satisfaction, period three
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Performance obligation expected to be satisfied (as a percent)	68%
Performance obligations expected to be satisfied, expected timing	10 years
Services | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-10-01 | Performance obligation satisfaction, period four
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Performance obligation expected to be satisfied (as a percent)	84%
Performance obligations expected to be satisfied, expected timing	15 years

SEGMENT INFORMATION - Summary o

SEGMENT INFORMATION - Summary of Reportable Segments (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Segment, Reconciliation of Other Items from Segments to Consolidated [Line Items]
Total revenues	$ 9,842	$ 9,302	$ 27,890	$ 25,893
Interest and other financial charges	(251)	(270)	(762)	(767)
Non-operating benefit income (cost)	207	244	628	731
Benefit (provision) for income taxes	(198)	(26)	(567)	(493)
Earnings (loss) from continuing operations attributable to common shareholders	1,705	215	4,766	7,970
Earnings (loss) from discontinued operations attributable to common shareholders	147	46	(108)	(371)
Net earnings (loss) attributable to common shareholders	1,852	261	4,657	7,599
Operating segments
Segment, Reconciliation of Other Items from Segments to Consolidated [Line Items]
Total revenues	9,246	8,662	26,186	23,972
Gross profit (loss)	2,019	1,814	5,717	4,819
Operating segments | Commercial Engines & Services
Segment, Reconciliation of Other Items from Segments to Consolidated [Line Items]
Total revenues	7,003	6,457	19,231	17,426
Gross profit (loss)	1,799	1,545	4,897	4,148
Operating segments | Defense & Propulsion Technologies
Segment, Reconciliation of Other Items from Segments to Consolidated [Line Items]
Total revenues	2,243	2,205	6,955	6,546
Gross profit (loss)	220	269	820	671
Corporate & Other
Segment, Reconciliation of Other Items from Segments to Consolidated [Line Items]
Total revenues	596	640	1,704	1,921
Gross profit (loss)	(73)	(1,455)	(252)	3,974
Segment reconciling items
Segment, Reconciliation of Other Items from Segments to Consolidated [Line Items]
Interest and other financial charges	(251)	(270)	(762)	(767)
Non-operating benefit income (cost)	207	244	628	731
Benefit (provision) for income taxes	(198)	(26)	(567)	(493)
Preferred stock dividends	$ 0	$ (91)	$ 0	$ (295)

SEGMENT INFORMATION - Schedule

SEGMENT INFORMATION - Schedule of Equipment and Services Revenues (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Disaggregation of Revenue [Line Items]
Total revenues	$ 9,842	$ 9,302	$ 27,890	$ 25,893
Operating segments
Disaggregation of Revenue [Line Items]
Total revenues	9,246	8,662	26,186	23,972
Operating segments | Commercial Engines & Services
Disaggregation of Revenue [Line Items]
Total revenues	7,003	6,457	19,231	17,426
Operating segments | Defense & Propulsion Technologies
Disaggregation of Revenue [Line Items]
Total revenues	2,243	2,205	6,955	6,546
Operating segments | Equipment
Disaggregation of Revenue [Line Items]
Total revenues	2,622	2,482	7,836	7,382
Operating segments | Equipment | Commercial Engines & Services
Disaggregation of Revenue [Line Items]
Total revenues	1,686	1,604	4,819	4,510
Operating segments | Equipment | Defense & Propulsion Technologies
Disaggregation of Revenue [Line Items]
Total revenues	936	878	3,017	2,871
Operating segments | Services
Disaggregation of Revenue [Line Items]
Total revenues	6,623	6,180	18,351	16,590
Operating segments | Services | Commercial Engines & Services
Disaggregation of Revenue [Line Items]
Total revenues	5,317	4,853	14,412	12,916
Operating segments | Services | Defense & Propulsion Technologies
Disaggregation of Revenue [Line Items]
Total revenues	$ 1,306	$ 1,327	$ 3,939	$ 3,674